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Chapter 1: Introduction 
Importance of virus identification 
As of October 31, 2002, there were 5738 virus species listed in the NCBI 
Taxonomy Database, an increase of 882 virus species in year 2001 alone. The number of 
new virus species listed each year in the Taxonomy Database is increasing (Figure 1-1 ). 
In 2002, ( as of October 31, 2002), 1033 new species have already been added. Since 
1039 virus species were known in 1993 and five times more virus species have been 
registered in less than ten years, only a small part of the viruses on earth is probably 
recognized currently (Condit, 2001). 
Newly identified diseases that cause public health problems locally or 
internationally are called emerging infectious diseases. Examples of emerging infectious 
disease associated with viruses are human immunodeficiency virus (HIV, isolated in 
1983 and causing AIDS), nipah virus (isolated in 1999 and causing encephalitis), ebola 
virus (isolated in 1977 and causing ebola hemorrhagic fever), hepatitis C (isolated in 
1989 and causing liver cirrhosis and/or liver cancer), sin nombre virus (isolated in 1993 
and causing highly fatal respiratory disease), and influenza A (H5Nl) virus (known 
pathogen in birds and first isolated from human case in 1997) (World Health 
Organization, WHO, http://www.who.int/inf-fs/en/fact097.html and 
http://www.who.int/inf-fs/en/fact262.html, viewed on Sept. 2, 2002). Since we have 
recently experienced outbreaks of viral diseases, it is certain that we will encounter more 
emerging infectious diseases and unidentified viruses that are potentially pathogenic to 
humans in the near future. 
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Figure 1-1, The number of virus species registered in NCBI taxonomy database from 
1993 to 2002. The number in year 2002 was as of October 31, 2002. 
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The human pathogenic viruses are not the only viruses important to us. Canadian 
and British researchers mainly targeted pathogens of animals and crops during World 
War II, and the US bioweapons program from 1945 to 1969 weaponized plant pathogens 
(Hilleman, 2002). Animals and crops are the sources of our food supplies, and food 
shortages become significant weaknesses during war. Economic damages cannot be 
ignored, either. Foot-and-mouth disease hit the UK in 2001. More than six million 
animals were slaughtered, costing £4.8 billion for compensation to farmers as well as 
disinfection, veterinary support and slaughter costs (Stone, 2002). 
Vaccination is used for prevention of some viral diseases. The development of a 
new vaccine takes 8 to 10 years and typically costs $ 500 million (Hilleman, 2002). 
Thus, it is not practical to expect vaccines for all human pathogens. Recently, fears of 
bioterrorism against civilians have come to the forefront. The Centers for Disease 
Control and Prevention (CDC) lists possible bioterrorism agents. Pathogens listed in 
category A, such as anthrax, smallpox and viral hemorrhagic fever, have the potential to 
cause the greatest impact on public health (Rotz et al., 2002). Preparation of vaccines for 
category A pathogens has not been completed. A vaccine against one of the viral 
hemorrhagic fever agents, yellow fever virus, has been licensed, but developments of 
vaccines for other viral hemorrhagic fever agents, such as ebola virus and lassa virus 
have not been completed. The current smallpox vaccination kills 2 persons in every 
million vaccinations (Hilleman, 2002). 
At this moment, our ability to prevent virus outbreak is limited. However, fears 
of biowarfare and bioterrorism are increasing, and fears from emerging infectious 
diseases also exist. For example, ebola was probably a local disease but development of 
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and human encroachment into rain forests and rapid international travel are responsible 
for the ebola now being a global threat (Larkin, 2000). In the midst of globalization, it is 
only to be expected that we will face additional threats from emerging infectious diseases 
like ebola. Early detection of outbreaks can facilitate initiation of effective counter-
measurements, such as rapid and accurate diagnosis and quarantine of infected 
individuals, animals and/or plants. Thus, rapid virus detection methods that cover wide 
varieties of viruses are indispensable. 
Current methods for diagnosing and identifying viruses 
In my MS thesis (Onodera, 1999), I studied the detection of the viral agents of 
bovine respiratory disease (BRD). The common methods to diagnose viral infection for 
BRD are virus isolation in cell culture, immunofluorescent antibody tests (IF A), 
necropsy, and serologic tests (Rocha et al. 1999, Loken 1995). Those tests present some 
disadvantages. Virus isolation tests are not very sensitive because some viruses grow 
with difficulty, and the tests may take 1 to 3 weeks to complete as in the case of Border 
disease in sheep (Loken 1995). Virus identification by serology and necropsy require 
either recovery or fatality of a bovine, respectively. This delays initiation of treatment for 
other cattle in the herd to avoid spread of these viruses. The immunoperoxidase plate 
assay can handle large numbers of samples simultaneously (Brock 1995), but this method 
also takes 5 to 7 working days to complete. 
PCR is the principal method of identifying virus genomes. Standard PCR cannot 
compare template concentrations because of the plateau effect (Kainz, 2000), which 
reduces amplification efficiency after PCR product concentrations reach too high levels. 
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The PCR amplification result is not known until all PCR cycles are completed. Recently, 
real-time PCR has become popular due to quantitation needs and the demand for faster 
diagnosis (Zubritsky 1999). There are many real-time PCR approaches. Two of them are 
to generate PCR products with two primers as in standard PCR with one fluorescent 
probe. These probes are exonuclease probes (TaqMan probes) and Molecular Beacon 
probes. The TaqMan probes are specific to an internal region of the PCR product and are 
labeled with a reporter fluorescent dye [FAM (6-carboxy-fluorescein)] and a quencher 
fluorescent dye [TAMRA (6-carboxy-tetramethyl-rhodamine)] 
(http://biochem.roche.com/lightcycler/lc_support/lc_faqs04.htm). A reporter and a 
quencher are located next to each other, so that the quencher absorbs energy from the 
excited reporter fluorophore. When the probe anneals to the PCR product, the quencher 
is removed by the exonuclease activity of Taq polymerase and the fluorescence from the 
reporter can be observed. 
More PCR product will lead to more annealing of the probes and thus more 
fluorescence. By monitoring the reaction in real time, this procedure can monitor PCR 
product quantitatively. Another approach to real-time PCR is similar, using Molecular 
Beacon probe. A Molecular Beacon contains a PCR product-specific hairpin loop and its 
3' and 5' ends are labeled by a quencher and a reporter fluorescent dye, respectively 
(Tyagi et al., 1996). This probe anneals to the PCR product, and straightens its hairpin 
region. When the probe looses the hairpin region, the distance between the quencher and 
the reporter is large enough to observe fluorescence. 
Other real-time PCR probes similar to TaqMan and Molecular Beacon are the 
Hybridization Probes from Roche (http://www.lightcycler-
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online.com/lc_principles/lc_prin_pcr_monOl.htm, viewed on Sept. 4, 2002). 
Hybridization Probes use two sequence-specific probes, one labeled with fluorescein and 
the other with LC Red 640. When the two probes are hybridized onto a PCR product and 
the two dyes are in close proximity (1 to 5 nucleotides), the excitation energy of 
fluorescein is transferred to LC Red 640, which emits light at a longer wavelength. The 
Amplifluor Uniprimer system also uses a hairpin region. Uniprimer contains a 5' hairpin 
region with a fluorophore at the 5' end and a quencher at the 3' end of the hairpin region 
along with a 3' tail sequence 
(http://www.serologicals.com/products/int_prod/body _per_ arnplifluor.html, viewed on 
Sept. 4, 2002). One of two PCR primers contains a 5' tail sequence. PCR products with 
tail-attached primers anneal to the tail region of the Uniprimer, and produce 5'end 
Uni primer-attached PCR products. The hairpin regions of the Uni primers are unfolded in 
the next PCR cycle and fluorescence can be observed. 
Another approach for real-time PCR uses an intercalating dye, such as SYBR 
Green I. SYBR Green I is a fluorescent probe and binds to the minor groove of the DNA 
double helix (http://www.lightcycler-online.com/lc _principles/le _prin _ dna _ detO 1.htm, 
viewed on Sept. 4, 2002). Thus, the fluorescence level increases with the increase of 
PCR products even if PCR products are primer-dimers or primer-artifacts. 
Real-time PCR is faster than soluble PCR, but it uses three to four types of 
oligonucleotides, two PCR primers and one or two fluorescent probes, or an intercalating 
dye. The intercalating dye cannot differentiate template-specific product from 
contaminants or artifacts. When we use more oligonucleotides with fluorescent probes, 
multiplex PCR specific problems arise. Multiplex PCR is used for simultaneous 
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amplification of two or more DNA fragments in the same reaction (Henegariu et al. 1999, 
Burgart 1992), and is used for DNA testing, including analyses of deletions, mutations 
and polymorphisms (Henegariu et al. 1999). As compared to single primer-pair PCR, 
multiplex PCR can reduce the total number of tubes, the cost for the reagents, and 
possible contamination (Burgart 1992). However, multiplex PCR is not suitable for 
monitoring and detecting emerging viruses or a wide range of viruses. Multiplex PCR is 
expected to be difficult for three reasons. First, competition among the multiplex PCR 
products makes it difficult to amplify viruses which are present in small amounts in the 
sample or which have low amplification efficiency during PCR (Boles et al. 1998, 
Weissensteiner et al. 1996). Second, size separation and identification of PCR products 
by gel electrophoresis may be difficult. This is because there are many fragment sizes to 
identify on the gel and the same size products are not necessarily the same PCR products. 
The need to identify the fragment sizes puts restrictions on the primer design. Third, 
primer-dimers and primer-artifacts may be a problem (Boles et al. 1998). It is possible 
that such products might interact with PCR products and make PCR products of 
unexpected sizes. 
Conventional PCR with gel electrophoresis is difficult to apply to virus 
monitoring systems due to multiplex PCR problems (Onodera 1999). Recently, 
microarray technology has become popular and many vendors are available. The most 
commonly used microarray technique is that a microscopic array of cDNA molecules is 
immobilized on a solid surface (i.e. nylon, nitrocellulose, and glass) as hybridization 
targets for biochemical analysis (Lemieux et al.1998, Schena et al. 1996). The cDNA 
array is printed on the solid surface as targets, and the mRNAs are labeled enzymatically 
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as fluorescent cDNA probes. These cDNAs are hybridized to the microarray and un-
incorporated labeled probes are washed away. Thus, a fluorescently labeled probe 
hybridizes specifically to the cDNA target. The fluorescence is detected by confocal 
laser scanning and charge-coupled device (CCD) imaging (Lemieux et al.1998, Schena et 
al. 1996). This method was developed for accurate measurement of the expression of the 
specific genes (Schena et al. 1996). Array densities are 400 to 250,000 cDNAs per cm2. 
This allows quantitative estimation of the expression of many genes in one single 
hybridization (Lemieux et al.1998). GSI Lumonics (Watertown, CA) developed a four-
color fluorescence detection scheme that allows up to four kinds of probes to be used in 
one expression analysis. Today, fluorescently labeled DNA or RNA from biological 
sources is used as probe and a complementary sequence is used as target (Lemieux et 
al.1998). The applications of microarrays have been extended to expression analysis, 
polymorphism detection, DNA resequencing, and genotyping on a genome scale 
(Lemieux et al.1998). 
Affymetrix (Santa Clara, CA) developed on-chip photolithographic synthesis, 
GeneChip technology. It can make miniaturized, high-density arrays of oligonucleotide 
probes by light-directed chemical synthesis. First, the protecting groups are removed to 
generate free hydroxyl groups at positions illuminated by UV light passing through the 
photo lithographic mask. Then, 5 '-protected phosphoramidite is added to deprotected 
sites, and oligonucleotide~. are synthesized by repeating this process (Ramsay 1998). 
Microarrays are not commonly used for detection of trace amounts of nucleotide 
sequences because microarrays cannot amplify nucleotide sequences. Mosaic 
Technologies, Inc. devised bridge amplification technology to overcome this shortfall 
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(Abrams et al. 1998, Rehman et al. 1999, Boles et al. 1998). They immobilized 
acrylamide-modified oligonucleotides on many kinds of media (i.e. nylon beads, optical 
fibers, glass plates) and performed immobilized PCR. The "bridge" of bridge 
amplification technology comes from the shape when the extension product from one 
primer binds to another primer during the annealing step (Boles et al. 1998). Many 
primer sets are placed on the media separately. This procedure should make it possible to 
diagnose tens to hundreds of individual amplification reactions in a single reaction 
mixture and vessel (Boles et al. 1998). The Mosaic Technologies' primer attachment 
method is co-polymerization of acrylamide-modified oligonucleotide into a 
polyacrylamide co-polymer (Rehman et al. 1999). The benefit of this method is that it 
can avoid cross-contamination from amplified products since all amplified products are · 
bound to the media. This system will be easier to automate and the use ofreal-time PCR 
is possible. Furthermore, this method costs less than a single template PCR for each 
primer since it can test many primers in a single assay (Boles et al. 1998). 
Because of the increasing availability of microarray systems, hybridization has 
begun to be used for viral or bacterial nucleic acid detection using pathogen-specific 
oligonucleotides. Liu, et al. (2001) used 16S rRNA specific oligonucleotides on a 
microarray to detect the presence of bacteria and attempted to differentiate among 
members of the genus Bacillus. In the bacterial detection system, twenty 
oligonucleotides were designed by a probe design program, ARB (Strunk and Ludwig, 
Technical University of Munich, Germany). Only 25 % of oligonucleotides were specific 
only to the expected species of Bacillus. In virus detection, enteric viruses and hepatitis 
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B virus were detected by a small number of virus-specific oligonucleotides on microarray 
chips (Jeong et al., 2002; Park et al., 2002). 
ViSA card and ViSH chip methods 
In my M.S. research, I experimented with Virus Signature Amplification (ViSA) 
card and Virus Signature Hybridization (ViSH) chip methods (Onodera, 1999; Onodera 
et al., 2002). The ViSA card and the ViSH methods are an immobilized PCR and 
hybridization methods, respectively, on a medium (i.e. nylon membrane or glass slide), 
on which virus-specific oligonucleotides have been attached. Both devices were tested 
for multiplex PCR of bovine herpesvirus type 1 (BHV-1) and bovine viral diarrhea virus 
(BVDV). Both BHV-1 and BVDV are viral agents ofBRD and they sometimes cause 
double infection (Fulton et al., 2000). Both viruses were successfully detected in 
multiplex PCR, but the amplified products in multiplex PCR were much lower in 
intensity than those in single PCR, and there were also PCR products of unexpected sizes. 
Non-specific products were probably due to unexpected interaction among primers, 
primer-dimers and PCR products. The interaction can be reduced using a ViSA card 
since all primer-pairs are immobilized on separated spots on a medium. In my M.S. 
thesis, primers were immobilized by UV light, which form a covalent bond between 
thymine and the amino group of the nylon membrane 
(http://www.stratagene.com/manuals/400072.pdf, viewed on Sept. 4, 2002). During the 
process ofViSA card modification, DMSO was found to inhibit PCR amplification on 
ViSA cards while DMSO was a required component for BHV-1 and BHV-2 
amplification in soluble PCR with the primer sets used. BHV-1 and BHV-2 were 
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detected without DMSO in ViSA card experiments as well as BVDV-1 and BVDV-2. 
There were two important factors in ViSA card experiments: primer and template 
concentrations. When one or both of their concentrations was high, the entire membrane 
reacted with the chemiluminescent substrate, which indicated the existence of PCR 
products, but the primer-spot was not identifiable due to a background problem. This 
was not a problem for the detection of single PCR products, but became a problem under 
multiplex detection since it was not possible to determine which primers produced the 
PCR product. Thus, template and primer concentrations were optimized for BHV-2 and 
BVDV-2 detections, and both viruses were successfully identified in a multiplex format 
in a ViSA card. 
ViSH chip experiments were also performed. Pl, P2 and TS2 are BVDV-2 
specific primers used in PCR experiments. Those primers were immobilized on silylated 
glass slides along with BHV-1 specific primers and border disease virus (BDV) specific 
primers. BDV and BVDV are both pestiviruses, and the ViSH chip could distinguish 
between them. BVDV-2 was amplified with Pl and P2 primers and hybridized on ViSH 
chip. The ViSH chip detected hybridization with P 1, P2 and TS2 primers. A negative 
control was prepared by amplification with Pl and P2 primers without template. It 
detected hybridization of PCR product only on P 1 primer. A soluble PCR experiment 
also produced primer-dimers with the primer set used. Thus, this may indicate that the 
Pl primer produced the primer-dimers or that the P2 primer part of the primer-dimer 
caused a hairpin and cannot hybridize with the P2 primer. 
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Needs of virus specific oligonucleotides for ViSA card and ViSH chip 
The ViSA card and ViSH chip results suggest that these methods can be 
candidates for universal virus detection systems. For further development, both methods 
require a number of virus-specific oligonucleotides as primers or probes. Two methods 
can identify virus-specific oligonucleotides for the ViSA card and ViSH chip methods. 
One approach was to use primer design programs, and another approach was to obtain 
such oligonucleotides from the published literature. 
Many programs are available for oligonucleotide design. For example, Oligo 
(Molecular Biology Insights, Inc. Cascade, CO), OMIGA (Accelrys, Inc. San Diego, CA) 
and Primer Premier 5 (PREMIER Biosoft International, Palo Alto, CA) are available for 
the design of primers, and Array Designer (PREMIER Biosoft International, Palo Alto, 
CA) is available for the design of oligonucleotide probes for microarrays. However, to 
conduct a PCR, several reaction conditions such as temperatures and times of the cycles 
and concentrations of buffer components may need to be optimized. Primer design 
programs only provide an estimate of annealing temperature (Ta). 
On the other hand, the published literature contains a number of virus-specific 
oligonucleotide sequences along with experimental conditions that have been tested. 
Even though DMSO was required in soluble PCR for BHV-1 and BHV-2 and ViSA card 
did not require DMSO, other PCR conditions were the same in ViSA card and soluble 
PCR. Thus, the PCR conditions in the published literature can be applied to ViSA card 
experiments, and oligonucleotides with the tested conditions from the published literature 
are more practical than those from design programs. The other imponderable problems 
of the oligonucleotide design programs are unknown specificity and annealing efficiency 
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of the oligonucleotides since the oligonucleotides have not been tested. As mentioned 
above, most oligonucleotides designed for 16S rRNA were not specific only to the target 
species. The oligonucleotides in the VirOligo database have been used in either PCR or 
hybridization at least once before publication, and many oligonucleotides have also been 
tested for specificity to differentiate among species or strains of the viruses. 
Publicly available oligonucleotide database 
Since a large number of oligonucleotides with experimental conditions are 
required for the ViSA card, making a database of oligonucleotides is absolutely 
imperative to avoid overlooking collected data. There are four PCR primer or 
oligonucleotide databases. EBI (European Bioinformatic Institute) has hosted the PCR 
primers database since 1996 (Shomer, 1996). It contains a total of 60 primer pairs as of 
Dec. 2000. Molecular Probe Database has accumulated 4300 oligonucleotide sequences 
as of Dec. 2000 since its creation was first published in 1992 (Grasso et al. 1998). Data 
are mainly taken from the literature. UK Human Genome Mapping Project Resource 
Centre offered Primer Bank until 7 July 1999, but it was withdrawn and no data are 
shown currently. Oligonucleotide Probe Database (OPD) contains 96 PCR primers and 
probes with experimental conditions along with brief results and references for 16S l 8S 
like SSU rRNA, 23S 28S like LSU rRNA, and ATPase8 from the li.terature (Alm et al. 
1996). None of these databases were updated in the past four years, and virus-specific 
oligonucleotides are not available from any of the existing databases. 
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Needs for PCR optimization protocols 
When PCR is performed for the first time with newly designed primers, 
optimization may be required (Boleda et al 1996), and the optimization is a time-
consuming and elaborate task. The costs (i.e. polymerase and labor) and the volume of 
PCR template increase with the number of optimization steps. 
PCR experiments without the optimization of PCR conditions usually generate 
fewer PCR products than the optimized experiments, and sometimes generate no PCR 
products (Sambrook and Russell, 2001 ). Optimization factors in PCR are Ta, length of 
each step ( denaturation, annealing and extension) in a cycle, the number of PCR cycles, 
buffer concentrations, MgCh concentration, concentration of dNTPs and sometimes the 
addition of additives such as DMSO, glycerol or bovine serum albumin (BSA) (Boleda, 
et al., 1996). Currently, we don't know which factors or whether all of these factors need 
to be optimized. PCR optimization kits are available from several manufactures, such as 
Invitrogen (Carlsbad, CA), Stratagene (La Jolla, CA) and Roche Diagnostics 
(Indianapolis, IN), but the kits are not sufficient for optimization due to the complex 
interactions ofreaction factors (Newton, 1995). Thus, trial-and-error approaches or 
empirical testing is used in the optimization and primer design process (Elfath, et al., 
2000; Boleda, et al., 1996). 
Recommendations for primer design 
Primer lengths 
Recommended approaches to primer design and reaction conditions have been 
widely disseminated in review articles and books (Sambrook and Russell, 2001; Newton 
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and Graham, 1997). However, those recommendations are inconsistent with each other. 
Primer length and G+C content are among the most mentioned considerations in PCR 
primer design. Some instructions recommend primers 18 nt or longer (Newton, 1995; 
Sambrook and Russell, 2001; Kidd and Ruano, 1995). The maximum recommended 
length of the primer varies: 30 nt (Newton, 1995; Taylor, 1991), 28 nt (Innis and Gelfand, 
1990), 25 nt (Sharrocks, 1994), and 24 nt (Dieffenbach, et al., 1993). Longer primers 
provide higher specificity. They also allow using higher Ta to reduce temperature 
differences among denaturation, annealing, and extension and make PCR cycles shorter 
(Newton, 1995; Rychlik, 1995). However, increasing primer length also increases the 
chances of primer-dimer formation. Since the long primers do not require annealing of 
the entire primer to the templates, the specificity of the PCR cannot be increased by 
adding more nucleotides at the 5' end of primers of adequate length (Newton and Graham, 
1997; Rychlik, 1995). 
Primer% (G+C) contents and melting temperatures (T,,,) 
40 to 60 % (G+C) contents of primers are generally recommended (Sambrook and 
Russell, 2001; Mitsuhashi, 1996; Newton, 1995), but some references recommended 
narrower ranges of%(G+C), 45 to 55 % (Sharrocks, 1994) and 50 to 60 % (Innis and 
Gelfand, 1990). Another reference recommended 40 to 65 % (Hyndman, et al., 1996). 
According to Sharrocks (1994), %(G+C) contents of the primers are related to binding 
strengths and melting efficiencies between templates and primers. Binding strengths and 
melting efficiencies can also be defined by Tm, but Tm of primer is not well discussed in 
the recommendations probably due to difficulty of accurate Tm calculations. Innis and 
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Gelfand (1990) recommended 55 to 80 °C for primer Tm. The difference in Tm between a 
pair of primers should be close to zero to avoid non-specific binding of less stable 
primers in a primer-pair (Kidd and Ruano, 1995; Sharrocks, 1994; Taylor, 1991; 
Hyndman, et al., 1996). 
The 3' end triplet codes of primers 
Along with the size and the G+C content of the primer, the 3' end triplet of a 
primer is also one of the considerations mentioned frequently in primer design. Although 
many researchers recognize the importance of the 3' end triplet, the recommendations are 
contradictory. According to Mitsuhashi (1996), a high G+C content at the 3' end of a 
primer may not require annealing of an entire primer for priming to occur with 
consequent loss of specificity. A low G+C content at the 3' end may not be elongated by 
DNA polymerase (Mitsuhashi, 1996) or may increase the importance of complete 
annealing (Hyndman, et al., 1996) due to weak annealing. Recommended compositions 
of primers at the 3' end triplets differ: no T at the 3' end and at least one W at the 3' end 
triplets (Kidd and Ruano, 1995); S at the 3' end and no GC or CG due to formation of 
hairpins and primer-dimers (Sambrook and Russell, 2001); low G+C (Hyndman, et al., 
1996); high G+C (Rychlik, 1995); 1 or 2 S (Sharrocks, 1994). 
Product sizes 
Less than 100 bp PCR products are difficult to differentiate from primer dimers 
by agarose gel electrophoresis, and large PCR products are generally difficult to amplify 
(Mitsuhashi, 1996). The recommended ranges for PCR products are 300 to 350 bp 
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(Mitsuhashi, 1996), 200 to 400 bp (Rychlik, 1995), 100 to 600 bp (Sharrocks, 1994), and 
120 to 300 bp (Dieffenbach, et al., 1993). 
Recommendations for PCR conditions 
Ta calculations 
Finding the right Ta is the most important thing in PCR optimization (Newton and 
Graham, 1997). At too high Ta, primers cannot anneal to template, and at too low Ta, 
primers may cause non-specific annealing to template (Newton and Graham, 1997). The 
ranges ofrecommended Ta also vary for different authors, 30-60 °C (Newton, 1995); 50-
65 °C (Burke, 1996); 55-72 °C (Innis and Gelfand, 1990); 45-65 °C (Mitsuhashi, 1996). 
T as in PCR experiments may be chosen based on melting temperature (Tm) of PCR 
primers. There are several recommendations for Ta: optimum Ta is three to five degrees 
below Tm of PCR primers (Newton and Graham, 1997; Sambrook and Russell, 2001 ); 
within a few degrees of Tm of PCR primers (Dieffenbach, et al., 1993); equal to Tm of 
PCR primers (Kidd and Ruano, 1995); Ta=0.7x[Tm of PCR product]+0.3x[Tm ofprimer]-
25 (°C) (Wetmur, 1991). 
Tm calculations 
All recommendations listed above deduce the Ta using the Tm of PCR primers. 
There are several methods to estimate Tm· 
For short oligonucleotides (18 nt or less; Ref, Howe, 1995): 
Tm (°C) = 4x [the number of G and C] + 2x [the number of A and T] (Eq. 1; 
Thein et al., 1986). 
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1962) 
For longer oligonucleotides (more than 19 nt; Howe, 1995): 
600 Tm= 81.5(°C) + 16.6log10 [Na+] + 0.4lx [%(G + C)]--. - (Eq. 2; Bolton et al., [Size] 
where [%(G+C)] and [Size] are %(G+C) contents and length (bp) of PCR 
product, respectively. 
For more precise calculation of Tm of short oligonucleotides, the nearest-neighbor 
method (SantaLucia, 1998) is used: 
M([ Na+]) = M([lM]) + 0.368 x N x ln[ Na+] [Eq. 3] 
Tm= Ml -273.15(°C) [Eq. 4] 
M+Rln(C/4) 
where ~H and ~S are the enthalpy and entropy for helix formation, respectively, 
N is the primer length-I, [Na+] is salt equivalent concentration, R is the molar gas 
constant, and C is the concentration of oligonucleotide. ~S values are available at lM 
NaCl and need to be adjusted for the PCR condition. 
The first two equations (Eq. 1 and 2) calculate Tm based on %(G+C) of the DNA 
sequence and the last one (nearest-neighbor) uses entropies and enthalpies of dinucleotide 
pairs. Salt equivalent concentration of 0.2 M ( equivalent to 1.5 mM MgCh and 50 mM 
KCl; Wetmur, 1991) was used in calculations using Eq.2 and 3, and ~Sis calculated by 
Eq.3 for use in Eq.4. 
Other parameters in a thermal cycle 
A thermal cycle consists of denaturation, annealing and extension. The Ta has 
been mentioned above. Recommended annealing time is not well discussed in review 
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articles and books. Newton (1995) recommended 5 to 30 seconds to achieve maximum 
fidelity and 2 to 3 minutes to achieve a maximum yield. 
Recommended denaturation temperatures and times are 92 to 95 °C for 5 to 30 
seconds (Newton, 1995), 94 to 97 °C (Innis and Gelfand, 1990), 94 °C for 1 minute 
(Kidd and Ruano, 1995) and 92 to 100 °C (Newton and Graham, 1997). High 
temperatures and longer denaturation can lower polymerase activity (Innis and Gelfand, 
1990) and damage template DNAs (Newton, 1995). In contrast, low denaturation 
temperatures cause incomplete denaturation and lower yield of PCR products (Innis and 
Gelfand, 1990). 
Extension temperature is dependent on polymerase activities (Newton, 1995). For 
example, the optimum temperature for Taq polymerase is 72 °C (Newton and Graham, 
1997). The length of extension depends on the product size, and usually 3 minutes 
(Newton, 1995) or 2 minutes (Newton and Graham, 1997) is sufficient. 
Mg2+ concentrations 
Mg2+ concentrations dramatically change the specificity and yield of PCR 
products (Newton and Graham, 1997). Mg2+ is a cofactor for the polymerase, and it 
simulates polymerase activity. However, the effects ofMg2+ concentrations are complex 
since dNTPs chelate Mg2+ (Kidd and Ruano, 1995), and changing dNTPs concentration 
requires re-optimization of Mg2+ concentrations. Low or high Mg2+ concentration may 
cause primer-dimers, weak or no products, or non-specific products (Newton and 
Graham, 1997). The range ofMg2+ concentrations recommended are wide; 0.5-2.5 mM 
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(Innis and Gelfand, 1990); 1.0-5.0 mM (Taylor, 1991); 0.5-2.0 mM (Mitsuhashi, 1996); 
0.5-5.0 mM (Newton, 1995). 
dNTPs concentrations 
Recommended ranges of each dNTP concentration are 200 µM (Kidd and Ruano, 
1995), 20 to 200 µM (Innis and Gelfand, 1990) and 10 to 100 µM (Newton and Graham, 
1997). According to Promega (Madison, WI), PCR buffer (Part No. M190A and 
M190G) supplied with polymerase is optimized at 200 µMeach of dNTPs. 
Primer concentrations 
High concentrations of primers cause the formations of the primer-dimers. 
Recommended ranges of primer concentrations are 0.1 to 1 µM (Newton, 1995), 0.1 to 
0.5 µM (Kidd and Ruano, 1995; Innis and Gelfand, 1990) and up to 1 µM (Newton and 
Graham, 1997). 
Other buffer components 
PCR buffer is usually supplied with the polymerase. For example, the PCR buffer 
from Promega (Madison, WI; Part No. M190A and M190G) for Taq DNA polymerase 
consists of 50 mM KCl, 10 mM Tris-HCl pH 9.0 at 25 °C and 0.1 % Triton X-100. 
Authors of PCR tutorial books recommend lower pH value than Promega's PCR buffer, 
such as pH 8.3 to 8.8 (Newton, 1995), 10 to 50 mM Tris-HCl pH 8.3 (Kidd and Ruano, 
1995) and 10 to 50 mM Tris-HCl pH 8.3 to 8.8 and up to 50mM KCl (Innis and Gelfand, 
1990). High pH (9.0-9.5) is recommended for long PCR products. High KCl 
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concentrations inhibit polymerase activities (Innis and Gelfand, 1990). Other effects 
. from buffer conditions are not well known (Innis and Gelfand, 1990). 
As the PCR buffer from Promega uses Triton X-100, other additives are 
sometimes mixed in the buffer. Triton X-100, Tween 20, Laureth 12, gelatin and bovine 
serum albumin (BSA) are added to stabilize polymerase (Kidd and Ruano; 1995; Innis 
and Gelfand, 1990). DMSO, glycerin, betaine, 7-deaza dGTP and dITP were added in 
the reaction mixture for the amplification of G+C rich templates (Henke, et al., 1997). 
However, Taq DNA polymerase activity drop approximately 50 % when 10 % DMSO is 
used in the reaction mixture (Innis and Gelfand, 1990). 
Primer design programs 
In the section above, three programs for the primer design (Oligo, OMIGA, 
Primer Premier) were introduced. At the default setting, primers are selected from18 to 
22 nt in length (all three programs); 40 to 60 % (G+C) (OMIGA); Tm of 45 to 65 °C 
(OMIGA) or 50 to 60 °C (Primer Premier); 400 to 800 bp product size (OMIGA) or 100 
to 500 (Primer Premier); Tm difference in a primer-pair of not more than 2 °C (OMIGA) 
or 3 °C (Primer Premier); primer length difference in a primer-pair ofless than 4 nt; the 
3' end GC clamp (all three programs); Tm is calculated by a nearest-neighbor method (all 
three programs); Ta is calculated by the Wetmur's equation (1991), Ta=0.7x[Tm of PCR 
product]+0.3x[Tm of primer]-25 (°C), in all three programs. In OMIGA, all primer-pairs 
are ranked according to the pre-determined score on each parameter. 
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Overview of the Dissertation 
Two approaches to obtain the oligonucleotide sequences for the ViSA card and 
the ViSH chip were introduced in the section above. Since PCR conditions needed in the 
ViSA card method are listed and oligonucleotide specificity has been tested in published 
literature as explained above, I decided to collect oligonucleotide sequences from the 
published literature. The collected sequences were compiled in the VirOligo database 
along with PCR and hybridization conditions (Chapter 3). To examine the usefulness of 
the VirOligo database created, the influenza virus specific oligonucleotides from the 
VirOligo database were tested as probes in ViSH chip and compared to oligonucleotides 
generated by primer design software (Chapter 4). Many publications are available giving 
tutorials for primer design and PCR optimization, but the recommendations are not 
consistent. Using the data from the VirOligo database, the range of each condition used 
the most frequently was analyzed, and the PCR optimization methods were suggested. 
Then, one of the suggestions was tested experimentally (Chapter 5 for primer design and 
Chapter 6 for PCR optimization). 
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Chapter 2: Materials and Methods 
Reagents 
TaqPlus Long DNA polymerase was purchased from Stratagene, La Jolla, CA. 
SYTO 61 was purchased from Molecular Probes, Inc., Eugene, OR. Cy3 and Cy5 Mono-
Reactive dye packs were purchased from Amersham Pharmacia Biotech, Arlington 
Heights, IL. 5-(3-aminoallyl)-2'-deoxyuridine 5'-triphosphate.(aa-dUTP) and 
hydroxylamine (50% wt solution in H20) were purchased from Sigma-Aldrich Corp., St. 
Louis, MO. Taq DNA polymerase in Buffer B, 1 Ox PCR buffer, and 25 mM MgCli was 
purchased from Promega, Madison, WI. lOx PCR buffer contains 10 mM Tris-HCl, 50 
mM KCl, and 0.1 % Triton X-100. Array it UniHyb was purchased from Telechem 
International, Inc., Sunnyvale, CA. Sodium borohydride and Tween 20 were purchased 
from Fisher Scientific, Pittsburgh, PA. M-ML V reverse transcriptase, RNaseOUT 
Ribonuclease Inhibitor, 5X first-strand buffer [250 mM Tris-HCl (pH 8.3), 375 mM KCl 
and 15 mM MgC12], and 100 bp DNA ladder were purchased from Invitrogen 
Corporation, Carlsbad, CA. 
TAE buffer consisted of 40 mM Tris-acetate and 1 mM EDTA (pH 8.2). TE 
buffer consisted of 10 mM Tris-HCl and 1 mM EDTA (pH 8.0). 20x SSC consisted of 3 
M NaCl and 0.3 M sodium citrate. Stop reagent consisted of 50% glycerol, 10 mM 
EDTA (pH 8.0), and 0.025% bromphenol blue. 
Materials 
Aldehyde slide plates (Cat.# ALS-25) were purchased from TeleChem 
International, Inc., Sunnyvale, CA. Microcon YM-30 was purchased from Millipore, 
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Bedford, MA. QIAquick PCR Purification Kit was purchased from Qiagen Inc., 
Valencia, CA. Hybridization Chamber (Cat.# 2551) was purchased from Coming, Inc., 
Coming,NY. 
Machines 
Fluorescent scanner used was ScanArray 3000 made by PerkinElmer Life 
Sciences Inc., Boston, MA. Arrayer used was PixSys 5500 made by Cartesian 
Technologies, Inc., Irvine, CA. PCR cyclers used were PTC-100 and PTC-200 made by 
MJ Research, Inc., Waltham, MA. PTZ-200 was a gradient thermal cycler and kindly 
provided by Dr. Muriana (Dept. of Animal Science, OSU). Gel Doc 1000 was made by 
Bio-Rad, Hercules, CA. Sonicator used was Fisher Model 60 Sonic Dismembrator made 
by Fisher Scientific, Pittsburgh, PA, and kindly provided by Dr. Longtine (Dept. of 
Biochemistry and Molecular Biology, OSU). Waterbath used was Fisher ISOTEMP 
1016S made by Fisher Scientific, Pittsburgh, PA. Speed Vac (scl lOA) was made by 
Thermo Savant, Holbrook, NY. 
Templates 
All templates were provided by Dr. Sengupta (Dept. of Biochemistry and 
Molecular Biology, OSU) and Dr. Lai (Dept. of Microbiology and Molecular Genetics, 
OSU). 
Influenza virus was propagated in chicken egg allantoic fluid, and RNA was 
extracted using phenol/chloroform, ethanol precipitated and resuspended in RNase free 
water according to Lai and Chambers (1995). 
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The reverse transcription (RT) mixture (20 µL) consisted of 5 µL of the 
resuspended influenza RNA sample, 0.2 µg or 0.08 µg of Uni3 universal primer 
(Appendix 1 for primer sequence), lX first strand buffer, 0.5 mM each dNTPs, and 3.2 u 
RNaseOUT. The RT mixture was incubated at 75°C for 3 minutes followed by 2 minutes 
on ice. Then 400 u M-MLV reverse transcriptase was added to the RT mixture and the 
mixture was further incubated at 42°C for 1 hour. By adding 80 µL sterile water, the 
total volume of the RT mixture was adjusted to 100 µL. 
Preparation of Cy-labeled targets 
Universal Amplification with aminoallyl-dUTP (aa-dUTP) 
PCR procedure was modified from the published universal PCR protocol for 
influenza A virus (Offringa, et al., 2000). The PCR mixture totaled 25 µL and included 
1.5 u TaqPlus Long polymerase, 1 x PCR buffer, 1.5 mM MgCli, 0.1 µg or 0.04 µg of 
Uni3 universal primers, 0.1 µg Uni5 universal primers (Appendix 1 for primer 
sequences), 0.14 mM dATP, dCTP and dGTP, 0.08 mM dTTP, 0.06 mM aa-dUTP and 2 
µL RT product. PCR was initiated with denaturation at 94 °C for 2 minute, followed by 
thirty cycles of denaturation at 94 °C for 1 minute, annealing at 40 °C for 2 minutes, and 
extension at 72 °C for 3 minutes. Final extension was allowed at 72 °C for 10 minutes. 
Coupling of Cy dye and aa-dUTP 
The PCR products were sonicated to less than 300 bp and small fragments less 
than 30,000 nominal molecular weight were removed by a Microcon centrifugal filter. 
Then, Cy dye was incubated with the PCR products for coupling and any un-reacted Cy 
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dye was quenched by adding hydroxylamine according to Seidel's protocol 
(http://www.pangloss.com/seidel/Protocols/amino-allylRT.html; viewed on Aug. 20, 
2002). Finally, quenched Cy dye was removed from the reaction mixture by QIAquick 
column, and the products were dried in a Speed V ac. 
Selection of oligonucleotide probes 
For oligonucleotide probes used in the ViSH chip, 463 influenza virus specific 
oligonucleotides were chosen from the VirOligo database and selected by omitting 
oligonucleotides less than 17 nt and more than 29 nt, and omitting those that had a perfect 
match or a 1 bp mismatch with an organism other than influenza virus in BLAST results. 
One 32 bp equine influenza virus-specific oligonucleotide was also included. Fourteen 
equine influenza hemagglutinin gene (A/Equine/Kentucky/98; Accession No. AF197241) 
specific oligonucleotide sequences were obtained using OMIGA software (Accelrys, San 
Diego) with OMIGA default settings, except that the number of primer pairs to be 
generated was set at 10. 
Attachment of oligonucleotide probes on an aldehyde glass slide 
Oligonucleotide probes (10 mg/mL, Appendix 1 for probe sequences) with 5' C6 
amino modification in 5x SSC were spotted in quadruplicate on an aldehyde glass slide 
by an arrayer. Then, the slide was dried and washed with 0.2% SDS solution for 1 
minute and with ddH20 for 1 minute twice. Next, the slide was incubated in sodium 
borohydride solution for 5 minutes, and washed with 0.2 % SDS solution for 1 minute 
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and with ddH20 for 1 minute twice. This slide was kept in the dark and room temperature 
until used. 
Detection of soluble PCR products by agarose gel electrophoresis 
Soluble PCR products were analyzed by agarose gel electrophoresis. Agarose 
gels (1.0 %) in lx TAE buffer contained 0.5 mg/mL ethidum bromide for detection of 
DNA. Samples loaded consisted of 5 µL PCR product, 4 µL stop reagent, and 10 µL 
ddH20. Electrophoresis was performed at 100 V (8 V/cm) in lx TAE buffer for 
approximately 40 minutes. A 100 bp ladder was used to determine product sizes. DNA 
was detected by Gel-Doc 1000. 
Hybridization and detection in ViSH chip 
Hybridization of a target 
Total 10 µL of hybridization solution (one volume of the resuspended Cy-labeled 
target and four volumes ofUniHyb hybridization solution) was pre-heated at 65 °C for 3 
minutes and shaken several times. Then, the solution was applied on a 2.2x2.2 mm #1 
thickness glass cover. The glass cover was placed on the printed ViSH chip in a 
hybridization chamber with 20 µL sterile water for humidity. This cassette was placed in 
a heated water bath for one hour at 22 °C. 
Detection of the hybridized target 
The chips were washed in 2x SSC and 0.2% SDS solution for 15 seconds and in 
0.5x SSC solution for 15 seconds in the dark. Then, they were dried by Kimwipes 
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without touching the probe printed area of the slide surfaces. Presence of Cy3 and Cy5 
was determined by a fluorescent scanner (ScanArray 3000) at 100 % laser and 95 % 
photomultiplier tube power. 
Oligonucleotide detection by SYTO 61 
The protocol for SYTO 61 was obtained from Microarray Core Facility's web 
page at OSU (http://opbs.okstate.edu/CORE/arrayer/files/SYT0-61.html; viewed on Aug. 
23, 2002). The printed ViSH chip was soaked in 50 mL of 1 µM SYTO 61 in lX TE 
buffer and 10% ethanol for 5 minutes at room temperature. The chip was washed with 
0.1 % Tween 20 solution for 5 minutes and with sterile water for 5 minutes twice. Then, 
the chip was dried by spinning at 500 to 1000 rpm in a HL-4 rotor of a GLC-2 centrifuge. 
The hybrids of SYTO 61 and probes were detected by ScanArray 3000 (using channel 2). 
PCR protocols for KY98 HA segment amplification 
The PCR mixture totaled 25 µL and included 2.5 u Taq DNA polymerase, 1 x 
PCR buffer, 1.5 mM MgC}i, 4 µMeach primer, 0.2 mM each dNTPs and 2 µL RT 
product. PCR was initiated with denaturation at 94 °C for 1 minute, followed by thirty 
cycles of denaturation at 94 °C for 1 minute, annealing at 42-72 °C for 1 minute, and 
extension at 72 °C for 1 minute. Final extension was performed at 72 °C for 10 minutes. 
Twelve different annealing temperatures were tested for each primer-pair by a gradient 
thermal cycler, PTZ-200. 
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Analysis of primers sequences and PCR conditions 
Primer sequences and PCR conditions were obtained from the VirOligo database 
on February 6, 2002 for the analysis. On that date, the VirOligo database covered a total 
of 1685 articles from Pub Med search results queried on December 19, 2001. The articles 
contained 3985 published virus-specific oligonucleotide sequences and 2300 PCR and 
hybridization conditions for detection of the viruses for alcelaphine herpesvirus, bovine 
adenovirus, bovine viral diarrhea virus, bovine herpesvirus (BHV), bovine respiratory 
syncytial virus, bovine rotavirus, bovine coronavirus, foot-and-mouth disease virus 
(FMV), variola (smallpox) virus, cowpox virus, and human adenovirus. The resulting list 
was filtered to eliminate redundancy. 
Data assortment and analysis were performed by homemade perl and php scripts 
(Appendix 2) along with Microsoft Excel 2000 and statistical analysis tools provided by 
Excel. 
Melting temperature 
Melting temperatures (Tm) for oligonucleotides were calculated by the nearest-
neighbor method using Eq. 3 and Eq. 4 in the Introduction. Because the nearest-neighbor 
method is only suitable to calculate T ms of short oligonucleotides, Tm of PCR products 
were obtained using Eq. 2 in the Introduction. 
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Chapter 3: The VirOligo Database 
The VirOligo database 
VirOligo is an oligonucleotide database that contains PCR primers and 
hybridization probes from published literature that are used for detection of viral 
nucleotides along with experimental conditions for their use (Onodera and Melcher, 
2002). As of September 2002, Vir0Iigo contained 4318 oligonucleotide sequences and 
3824 experimental conditions from 2874 articles. Currently, Vir0Iigo covers all virus-
specific oligonucleotide sequences available in the articles listed in PubMed search result 
queried on March 5, 2002 for bovine adenovirus, bovine parainfluenza, influenza virus, 
alcelaphine herpesvirus, bovine viral diarrhea virus, bovine herpesvirus, bovine 
respiratory syncytial virus, bovine rotavirus, bovine rhinovirus, bovine enterovirus, 
bovine coronavirus, foot-and-mouth disease virus, variola (smallpox) virus, cowpox 
virus, human adenovirus, and vaccinia virus. The coverage ofVirOligo is being 
expanded to other viruses, and bovine parvovirus, canine parvovirus, porcine parvovirus, 
and rodent parvovirus are nearly completed. Simultaneously, Vir0Iigo is being updated 
with newly published articles for the existing virus coverage, and almost all articles listed 
in PubMed search queried on March 25, 2002 are being added to Vir0Iigo. 
Evolution of Vir0Iigo 
A prototype ofVirOligo was created in October 2000 to provide a large number 
of virus specific PCR primers for ViSA card experiments (Onodera, et al., 2002). That 
VirOligo was a flatfile database, and was constructed with FileMaker Pro, ver. 4 
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(FileMaker, Inc., a subsidiary of Apple Computer, Inc). PCR conditions and primer 
sequences were entered at the same time by an undergraduate student using an internet 
browser from a website created for VirOligo. The prototype contained the same entry 
fields as the current version of the VirOligo database, but expected the entry person to 
enter only one pair of oligonucleotides. Further, the same PCR conditions needed to be 
entered twice for each pair of primers since each entry took only one oligonucleotide 
sequence. Some types of PCR, such as nested PCR and multiplex PCR, use more than 
two primers. 
The current version of the VirOligo entry system was created in December 2000. 
It allows entry of more than one pair of primers for a set of PCR conditions and will 
accept any virus-specific oligonucleotides. The system is a relational database consisting 
of two tables, Common data and Oligo data. The Oligo data table contains 
oligonucleotide sequences and the Common data table contains the experimental 
conditions. Since the Oligo data and the Common data are stored separately, the same 
oligonucleotide sequence can be used in several PCR or hybridization condition entries. 
Conversely, entries in the Common data table allow up to ten oligonucleotides to be 
linked to them and can thus be used for multiplex and nested PCRs. This version of the 
VirOligo entry system is well established and has been used for 22 months as of October 
2002. 
After the VirOligo database was launched, twelve graduate and undergraduate 
students, including freshmen, tested data entry methods. The number of students 
involved dictated that labor distribution and training needed to be optimized. We 
considered whether students should work together or individually. 
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The benefits of group work compared to individual work were that, since entry 
people can specialize in one job function, less knowledge was required of beginners and 
that more proofing occurs for each entry. The entry task was separated into four job 
functions: literature collection, filtering articles (removing articles without primers, or 
with primers used for PCR-mediated cloning experiments), oligonucleotide entry and 
experimental condition data entry. At the early stages of the project, filtering and 
literature collection were combined. The literature collection task included literature 
management to avoid missing articles from among the hundreds surveyed and keeping 
the database of articles updated. 
It is critical that VirOligo provide oligonucleotide sequences without 
typographical errors. The oligonucleotide entry person entered the sequence and wrote 
the Oligo ID (identification number for each oligonucleotide entry) on the article. Then, 
the common data person received the article and found the Oligo ID. After entering the 
common data, the common data person linked the Oligo ID into the Common data and 
double-checked the sequence for correctness. Becam~e the job functions and working 
schedules of the participants were different, stresses were occasionally induced against 
other job functions. These were resolved through weekly staff meetings. 
In individual work, each person did the entire job from literature collection based 
on PubMed Identifier numbers (PMID) to data entries. Undergraduate students had to 
learn a lot, such as how to request articles by interlibrary loan, how to use BLAST and 
how to calculate concentrations. Every author has his/her own style of writing, and it 
was sometimes difficult to decipher what was meant. For example, some authors write 
the volume of dNTPs added in RT and PCR separately. The molarity calculation 
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becomes complex for some undergraduate students if a part of a cDNA reaction was used 
inPCR. 
The biggest benefit of individual work was that all workers understood the entire 
job and the database did not suffer a shortage of workers when one person quit. If there 
is only one person for one job shift in the group work, the entire job will be stopped by 
missing the job shift, but in individual work, there are no concerns from one missing 
shift. 
The VirOligo database project started with the individual working plan. A two 
day training session covered the gamut from math and basic biology to PCR techniques. 
The individual work plan was not successful since most students had difficulty reading 
and understanding journal articles. The group-work plan was started to reduce the 
amount each individual had to learn. The group-work plan operated smoothly, and all 
personnel contributed well. The filtering of articles was assigned to the literature 
preparation shift, but the filtering job was harder for students than expected. The filtering 
person needed to read the articles and understand whether the oligonucleotides were 
virus-specific. Thus, the filtering task has become the common data entry person's task 
or one independent task. 
During Fall 2001, the expansion of viruses covered in VirOligo made it difficult 
to track the articles, whether they needed to be obtained from the libraries or to be put on 
hold waiting for an interlibrary loan return. Overcoming the difficulty thus required 
improvement of literature collection and management tasks. As a result, a Literature 
Management System (LMS) was introduced (see below). 
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Due to concerns with computer stability with FileMaker Pro and the computer's 
processing speed, a Publishing Server for the VirOligo database was established. It uses 
the Linux operating system and Perl scripts, a MySQL database, an Apache web server 
and PHP web-scripts. It also is described in more detail below. 
All preparations and modifications for VirOligo were made by the end of 2001, 
and the VirOligo database was finally opened for the public by announcing VirOligo in 
Nucleic Acids Research, Database issue 2002. VirOligo initially covered ten bovine 
viruses (bovine herpesvirus, bovine viral diarrhea virus, bovine adenovirus, bovine 
parainfluenza virus, bovine respiratory syncytial virus, bovine rhinovirus, bovine 
coronavirus, bovine reovirus, bovine enterovirus, and alcelaphine herpesvirus). As 
mentioned above, the number of viruses covered has expanded to 16 viruses, and has 
been updated for existing viruses. 
The VirOligo System 
The VirOligo database system consists of two servers, the Publishing Server and 
the Entry Server, and the Literature Management System. The servers are separated to 
achieve better security and performance. 
A team of student workers was assembled to extract the details of 
oligonucleotides used in virus detection from research articles identified and managed by 
the Literature Management System. Entered via the Entry Server are the sequence of the 
oligonucleotide, the virus name, its NCBI taxonomy ID, reference GI number to the virus 
sequence in GenBank, and the position in that sequence that the oligonucleotide 
corresponds to. Additional! y, if the oligonucleotide is part of a PCR primer pair, 
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information on the PCR conditions (temperatures, buffer concentrations, divalent cation 
concentrations, etc.) are added. The database is searchable. Results are presented via the 
Publishing Server with links to a BLASTn search of GenBank, and to the relevant 
PubMed, GenBank and Taxonomy entries. Calculated information such as melting 
temperature, product length, oligonucleotide length and degeneracy are also presented. 
To make VirOligo useful to the virological community as soon as possible, we 
elected to approach filling the database one virus or group of related viruses at a time. To 
date, we believe to have achieved complete coverage of oligonucleotides published in the 
literature that are related to the approximately dozen viruses associated with bovine 
respiratory disease, foot and mouth disease virus, human adenovirus, variola and cowpox 
viruses, and influenza virus. In addition, about a hundred other viruses are partially 
covered. For all viruses, as of January 2002, 1,232 PCRs were covered. The team 
examined 1,510 articles and entered 3,799 oligonucleotides. This number of 
oligonucleotides is substantially higher than in other available databases of 
oligonucleotides (Campi et al., 1998; Alm et al., 1996; Shomer, 1996). 
The VirOligo Entry Server 
The Entry Server is used solely for database entry. Our database group staff and 
students are the only users. The Entry Server is embedded in FileMaker Pro version 4 
under Microsoft windows 98 OS and is dedicated to this purpose. Since other software, 
such as an E-mail client, is not running, there is little fear of computer virus infection. 
Most security breeches are the result of known security holes attacked with automated 
hacking software (http ://www.cert.org/archive/pdf/attack_ trends. pdf, CERT Coordination 
' 
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Center, Carnegie Mellon University, viewed on May, 9, 2002). Since FileMaker 
software is not popular and the currently marketed version ofFileMaker is 5.5, 
information about security holes of version 4 is not easily available. We believe that 
unpopular software is safer than popular software, and automated hacking software for 
FileMaker, especially for version 4, is less likely to be created and used. As an extra 
precaution, the database files are regularly transferred to another computer for backup. 
The Entry Server contains seven tables: Common data, Oligo data, User data, 
Oligo user data, bulletin board, working hours, and Security database. The Security 
database possesses user ID and password information, and is used for user authentication 
when a user accesses the database to create or modify an entry. Information extracted 
from articles is entered into two tables. Oligonucleotide information is put into the Oligo 
data table and experimental conditions for PCR and hybridization are put into the 
Common data table. Each Oligo data entry consists of oligonucleotide sequence, target 
region, name of the oligonucleotide, type of usage (PCR primer, PCR probe, 
hybridization or other), notes and direction of the oligonucleotide (forward or reverse). 
Degeneracy and length are calculated by FileMaker automatically upon the entry of an 
oligonucleotide. Dissociation temperatures (T d) of oligonucleotides are calculated by 
FileMaker scripts. 
Initially, Common data were entered first, and then, the Oligo data were added to 
the Common data. This method did not allow entries beginning with the Oligo data. 
Oligonucleotide sequences are the most important in VirOligo and a typographical error 
will reduce the creditability of the database. Thus, the oligonucleotide sequences should 
be entered first and the sequences should be confirmed by another person during the 
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Common data entries. Thus, a :function was added during Spring 2001 to enable the 
Oligo data entry before the Common data entry. 
Currently, Oligo data personnel enter Oligo data first. On completion of data 
entry they write the Oligo IDs provided by the server on a copy of the article along with 
GI numbers. Then, the Common data personnel receive the articles and perform the 
Common data entry. Each Common data entry contains publication date of the reference, 
its PMID (PubMed unique identifier), GI (GenBank) of the target virus sequence, virus 
name, virus taxonomy ID (NCBI Taxonomy database), PCR cycle or hybridization 
temperature, buffer, dNTPs and MgCh concentrations, polymerase used, PCR product 
size, note, type of hybridization or PCR (i.e. nested PCR) and a curator checking field. 
The latter is used by the curator to mark whether the entry was verified by the curator. If 
this field is marked as "Fix", the notification appears on the user's web page. The note 
field contains additional information, such as reverse transcription conditions or unique 
features of each entry. A nested PCR is either entered as one entry or separated into two 
or more entries. If the PCR conditions, in general, are different between first and second 
amplifications in the nested PCR, each amplification condition is entered separately. 
When a nested PCR is one entry, all Oligo data are listed in one Common data entry and 
information for primer-pairs are written in the note field. If a nested PCR is separated in 
two or more entries, each Common data entry contains one primer-pair, and VirOligo IDs 
for other nested PCRs are written in the note field in the VirOligo specific format. 
The VirOligo database uses identifiers to link to other data sources. If one article 
has several entries (i.e. nested PCR), the identifier used is "[see VirOligo ID]". When the 
PHP script in the Publishing Server recognizes the "[see******]" identifier, the script in 
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the Publishing Server modifies the identifier as a clickable link to another entry. Further 
identifiers, "[PMID: ******]","[GI:******]", "[Taxonomy:******]" link to the 
PubMed, GenBank and Taxonomy databases, respectively. 
User data and Oligo user data tables are used for assigning VirOligo IDs and 
Oligo IDs, respectively. They store newly added data IDs for each user in the Entry 
Server. Every time users log in to the Entry Server, users are transferred to a user page or 
an Oligo user page depending on user-selection. Users can select whether they wish to 
modify the entry or create a new entry. If creating a new entry is selected, FileMaker 
assigns the latest data ID plus one as a data ID, and automatically enters it on the entry 
page. 
At login and logout, users are required to use a punch clock and bulletin board 
web page. Punch clock data and bulletin board data are stored in a working hours table 
and.a bulletin board table, respectively. Punch clock data are pasted to an Excel spread 
sheet file so that total working time for each user can be calculated automatically. The 
bulletin board web page is used for communication among participants. For example, a 
Common data entry person may ask an Oligo data entry person to fix an oligonucleotide 
sequence, or each user may report their accomplishments at the end of day. 
All entries are stored in the Entry Server and backup is performed by MS-DOS 
scripts with the Window 98 embedded scheduled task program hourly from 9 AM to 7 
PM for Common data and Oligo data files and every day at 4 AM for all database files. 
The files are not transferred to the Publishing Server until the curator verifies all entries. 
In addition, with each new virus, transfer does not occur until all articles for that virus are 
completed. 
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As mentioned above, oligonucleotide sequences are reconfirmed by Common data 
personnel, and all entries are checked by the curator. The curator verifies that reagent 
concentrations and PCR cycle values are reasonable. The curator web page contains 
automated links to PMID, GI and Taxonomy ID, and those are randomly checked by 
clicking the links and viewing the linked web sites. The curator confirms that 
oligonucleotide sequences are consistent with the lengths of oligonucleotides and the 
sizes of target regions. When the lengths and the sizes of target entered by an Oligo data 
person differ considerably from expectation, the curator checks all oligonucleotide 
sequences entered by that person by comparison with the original articles. 
Additionally, a molarity calculator written by Java script has been made available 
from the Entry Server website. The calculator helps users who have difficulty in molarity 
calculations. It solves a final concentration in PCR reagent from initial concentrations 
and volumes added to PCR reagent and the total volume of PCR reagent. It also solves 
the final concentration when the same chemical is added separately at reverse 
transcription and at PCR. 
The VirOligo Publishing Server 
The Publishing Server runs under the Linux operating system with the popular 
web server program, Apache. Apache uses a structured query language, MySQL, for 
handling the database, and a script language, PHP, to create dynamic web pages, to 
search for related experimental conditions and to automatically add links to the NCBI 
databases. The set of programs for the Publishing Server were selected to provide users 
faster access to the database. FileMaker version 4 does not have enough functions to 
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create dynamic web pages. Searching the database and formatting dynamic web pages 
requires more computational power than adding entries, and the processing speed of 
FileMaker version 4 was not sufficient for the Publishing Server. The Publishing Server 
was compromised once in December 2001 during the testing period. The cause was a 
security hole and a patch that had not been applied promptly. However, since all 
VirOligo data is stored in the Entry Server and the backup computer, the recovery 
process went smoothly. To prevent future security breeches, new security patches are 
applied within 24 hours of receipt of announcements from the Linux vendor using an 
email notification system offered by RedHat. At the same time, we also subscribe to 
CERT security alert to fix security holes before RedHat's security patches become 
available. 
The Publishing Server uses MySQL as a database program and differs from the 
Entry Server. Thus, database files from the Entry Server need to be converted to a 
MySQL acceptable format. Both programs accept tab-separated files and comma-
separated files, but those formats cannot be used since some entries contain tabs in the 
note field and the comma-separated file formats are slightly different between the two 
programs. In the VirOligo database system, database files are exported in HTML table 
format from the Entry Server and converted by a Perl script to a homemade format, 
which is similar to a comma-separated format. Converted files are transferred by secured 
shell (SSH) and added to the MySQL database in the Publishing Server. 
The Publishing Server consists of two MySQL tables, Common data and Oligo 
data, and a PHP query retrieval server-side includes (SSI). The fields contained in the 
two tables are the same as those in the Entry Server except that the curator checking field 
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used by the curator is omitted. Besides converting homemade identifiers to links to 
NCBI, the PHP script searches the database and creates dynamic web pages with 
summarized or detailed results. An oligonucleotide selection method was developed to 
provide user-friendly access to the oligonucleotide data. Users needing a common PCR 
cycle to detect several viruses can select oligonucleotides based on viral specificity and 
Tct. Users can compare oligonucleotides from a variety of fields, such as the target gene 
of viruses and oligonucleotide length. Search queries can be initiated with virus name, 
T d, length of oligonucleotide, PMID or the VirOligo ID number. A summarized result is 
presented with virus name, oligonucleotide name and use, type of experiment (i.e. type of 
PCR), PCR cycle, Tct, publication date and PMID with the VirOligo ID number. By 
clicking the VirOligo ID number for each result, users can see the complete information 
for the identified entry. The detailed result has direct links inserted by the PHP script to 
BLAST for each oligonucleotide sequence, so that users can check up-to-date knowledge 
about the specificity of the oligonucleotide without typing the oligonucleotide sequences 
themselves. 
The VirOligo database is able to accept volunteer data entries from colleagues. 
Since volunteers do not have User IDs needed by the Entry Server and the location of the 
Entry Server is not published due to security reasons, volunteer entries are handled in the 
Publishing Server. The Publishing Server possesses an empty set of the Common data 
and the Oligo data tables in addition to the one used for the VirOligo website. Volunteer 
entries are temporarily stored in these tables. Affiliations of volunteers are entered in the 
note field of the Common data. The website for volunteer entry has been available for 
four months, but no volunteer entry has yet been made. This lack is probably due to 
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insufficient advertisement and the requirement for the entry of detailed information. As 
5 8 primer sequences were entered by 15 volunteers in the Primers database in one and 
half years (Shomer, 1996), VirOligo could expect some volunteers if the volunteer entry 
asks only for oligonucleotide sequences. However, such a policy just brings uncertain 
oligonucleotide entries, and will be against the spirit ofVirOligo. 
The VirOligo Literature Management System 
The expansion of viruses covered in the VirOligo database made literature 
collection tasks more complex. At early stages of the database, entry personnel printed 
the Pub Med search results for each virus and marked articles off when they were 
obtained. Many articles are obtained through the Inter-Library Loan (ILL) system from 
which it takes up to months to receive articles. Finding the articles that were ILL 
requested and received in the PubMed print-outs became very time-consuming. As a 
result, a Literature Management System (LMS) was established. The idea of LMS 
derived from PubCrawler, a program to search newly added data in PubMed and 
GenBank (Hokamp & Wolfe, 1999). LSM obtains from PubMed a list of articles needed 
for the VirOligo processing and, upon user request, creates a list of articles along with the 
articles' physical locations. PubCrawler, written only in the script language Perl, was too 
complex for our application. Perl is a general purpose language, and can be used as the 
sole program for database and CGI in the web. However, the specialized programs such 
as MySQL for databases and PHP for a website program were easier to program for our 
purposes and sometimes operate faster. Thus, LMS was created in Perl borrowing the 
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concepts from PubCrawler but using code sets that incorporated the use of MySQL and 
PHP scripts. 
The LMS system consists of four MySQL tables (Journal Location, PMIDList, 
userdata and Reserved), three Perl scripts to obtain article information from PubMed and 
the Entry Server ofVirOligo, and one PHP script to search the database and create a 
dynamic web page for users. Queries of articles being searched by LMS are stored in 
PMID.config in a PubMed query format of"virus name AND (PCR OR 
oligonucleotide)". Perl script 1 sends the queries to PubMed and compares returned 
PMIDs with PMIDs in a MySQL table, PMIDList. Then, Perl script 1 stores the unique 
PMIDs in PMIDList. Perl script 2 sends the newly added PMIDs, whose entries do not 
have VirOligo IDs in the Publishing Server, to the VirOligo Entry Server, and obtains the 
VirOligo IDs if the articles have been entered in the Entry Server. Perl script 3 obtains 
from PubMed and stores in the PMIDList detailed information Gournal title, article title, 
authors, published date, volume, issue, and page numbers) of newly added articles 
without VirOligo IDs in either server. 
When accessing the LMS, a user is asked for a password and username. 
Username and password are compared to a MySQL table, userdata, and verified by a 
PHP script. After verification, a web page asks for the number of articles requested, and 
selections oflocations from Main Library, Vet Medicine Library, Online and ILL. After 
user selection, the PHP script obtains an article without a VirOligo ID from the 
PMIDList, and checks whether the PMID of the article is not listed in the 'Reserved' 
table and what the location of the article is. If the article is in the 'Reserved' table and 
the reservation has not expired, or the article location is different from the user's request, 
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the PHP script searches for the next article. If the article reservation has expired or the 
article is absent from the 'Reserved' table and the article location matches the user's 
request, the PMID for the article is stored in the 'Reserved' table along with the user who 
requested it, the current time and expiration time. Then, detailed information about the 
article (PMID, article title, authors, journal title, volume, issue, page numbers, and call 
number assigned by the library or URL if the article is available onliiJe) appear on the 
web page. No searching of locations is required. The PHP script repeats the above 
process until the number of articles that the user requested is obtained. Since a call 
number or a URL is in the list, the person simply prints the list and finds the articles. The 
script also calculates estimated copying costs from the number of pages copied. 
Expiration time for the 'Reserved' table is set to assign the article to another person when 
a certain time period has passed. Expiration time is currently set at 20 minutes for online 
articles and 2 days for Main and Veterinary Medicine Libraries. If ILL is selected, the 
PHP script obtains personal information required by the ILL office from the userdata 
table, and creates an ILL request form for articles. Priority is set for the locations 
searched. If the article is available online, it does not appear in the list for Libraries or 
ILL. Only the articles that are not available elsewhere are requested from ILL. 
Common mistakes in journal articles 
In the process of the VirOligo data entry, a number of mistakes in journal articles 
were found. Although those were all kinds of careless mistakes made by authors, some 
mistakes were repeatedly found in the articles. Many common mistakes concerned 
oligonucleotide sequences and their target regions. Lengths of oligonucleotides were 
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sometimes one nucleotide shorter or longer than lengths estimated from the target 
regions. For example, a target region was written as 200-220 when a 20 nt long 
oligonucleotide has a target region of 200-219. The length of an oligonucleotide with 
target region of 200-220 is 21 nt. Another common mistake in oligonucleotide sequences 
were that a pair of primers consists of two forward or two reverse primers based on 
BLAST searches. It was probably caused by the authors finding primer sequences from a 
genome sequence during writing a manuscript, and forgetting to write a complementary 
sequence. These mistakes can be easily avoided by BLAST search before writing a 
manuscript. 
Units in the journal articles also commonly contained mistakes. One PCR tube 
usually contains 10 to 50 µL of PCR reagents. Instead of 10 to 50 µL, some articles 
wrote a PCR volume as 50 mL. The interchanges of units can be caused in computer 
programs. When word processor files containing"µ" are converted to text files or pasted 
into e-mail, computer programs change "µ" into "m" since ASCII text format does not 
have "µ" defined. Thus, authors should take care of some special characters when files 
are converted. 
Current coverage in Vir0Iigo 
As of May 2002, the VirOligo database contained 16 completed viruses and is 
being expanded. The strategy adopted to fill the database was to obtain as near complete 
coverage as possible of one group of viruses at a time. For each new virus, articles are 
identified whose PubMed abstract contains the virus name and 'PCR' or 
'oligonucleotide'. Since the PubMed searches retrieve all articles with a particular virus 
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name, articles do contain oligonucleotides specific to viruses other than the searched 
viruses. Thus, after the completion of entries for sixteen viruses, the VirOligo Entry 
Server contained oligonucleotides for more than 100 viruses. 
VirOligo was established as a means to create ViSH chips and ViSA cards so that 
one can monitor and survey the environment for the appearance of novel viruses or the 
disappearance of existing viruses. However, feedback from VirOligo users indicates that 
the database is found useful by diagnostic laboratories since it simplifies their searches 
for assays to detect particular viruses. 
To assess the reputation of the database, access events were monitored. More than 
1200 visitors accessed the index page of the VirOligo database in the first 4 months of 
2002 (the number excludes any accesses made within one minute of each other from the 
same access point). Since some accesses directly obtain the database search results 
through links in web pages, such as Yahoo and Google, a larger number of visitors 
probably occurred. The number of searches made in the VirOligo database were more 
than 7400 in the four months ending April 30, 2002. A related database, MPDB, was 
published in Nucleic Acid Research six times, and 554 searches were made by its users in 
eight months from January 1997 to August 1997 (Campi et al., 1998). Thus, people's 
interest in the VirOligo database is significantly higher than in another oligonucleotide 
database. Science introduced the VirOligo database in their Net Watch column (Vol 295, 
Issue 5561). 
The number of websites with links introducing the VirOligo database is 
increasing. Websites simply listing databases introduced in the Nucleic Acids Research 
Database issue were excluded from the following analysis. A wide variety of academic 
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institutions display links to VirOligo. VirOligo is linked from professional organizations 
(ASM, Ohio Branch; The American Phytopathological Society), university libraries 
(University of Manitoba Libraries; Westfalische Wilhelms-Universitiit Munster, 
Germany), scientific institutes (Universita di Genova, Department of Surgical 
Specialistiche Sciences, Anesthesiology and Transplant of Organs, Italy; Institut Pasteur, 
France; Institute of Biochemistry, University of Provence, France; Biological Research 
Information Center, The Pohang University of Science and Technology, Korea; Institute 
of Animal Health, UK), academic projects (Virology down under, The University of 
Queensland, Australia; Internet Scout Project, The NSDL Scout Report for Life Sciences, 
Computer Sciences Department, University of Wisconsin-Madison) and a museum 
(Exploratorium, the museum of science, art, and human perception at San Francisco). 
Moreover, the links are not only from US institutions but also foreign institutions. Thus, 
the VirOligo database has been globally recognized just four months after its first 
announcement. 
Conclusions 
The reputation ofVirOligo is rapidly growing. The collection of virus-specific 
oligonucleotides is unique and can be used not only for finding proven PCR methods for 
listed viruses but also for finding optimum PCR conditions for all viruses and obtaining 
oligonucleotides to detect a wide variety of viruses in one trial by the microarray 
methods, such as ViSA and ViSH. The system ofVirOligo is stable and well designed 
for continuous future usage. However, it is still a starting point, and VirOligo needs 
wider virus coverage. As of May 13, 2002, 39,479 articles of PubMed contain 'virus' 
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and 'PCR' or "oligonucleotide' in their abstracts, and VirOligo contains approximately 
six percent of the 39,479 articles. Collecting all the articles in PubMed will help 
researchers in many ways, and ViSH chips or ViSA cards that detect all viruses in one 
experiment will be possible. More accurate analysis of PCR conditions is also possible 
with more oligonucleotides. The VirOligo database is available from the publishing 
server at http://viroligo.okstate.edu/. All entries in the entry server are transferred 
immediately after curator's verification. 
Possible additional modules for VirOligo in the near future 
Boosting data entry speed simply needs more manpower, but entry can be more 
efficient with additional functions listed in next sections. 
BLAST for PCR primers 
Currently, Oligo data entry requires GI numbers unless GI or Accession numbers 
are listed in the article. To obtain GI numbers for PCR primers, Oligo entry personnel 
perform BLAST for each primer. PCR usually uses a pair of primers, so that Oligo entry 
personnel obtain two BLAST results. In the case of nested PCR or multiplex PCR, the 
number of BLAST results is more than two. The number of perfect matches with the 
primer sequences in BLAST results sometimes exceeds fifty GenBank nucleotide entries, 
and each entry has its own GI number. The entry personnel need to compare more than 
two BLAST results and find one GI number matched with both ( or more in the case of 
more complex PCRs) BLAST results. When BLAST results contain more than fifty 
perfect matches, more than one GI number often matches in both results, and the entry 
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person selects one GI number by finding the virus name used in the article. If the entry 
person overlooks matched GI numbers or enters the wrong sequence, finding a GI 
number causes a lot of confusion. It sometimes took more than one hour to select a GI 
number. VirOligo uses NCBI BLAST search, but it is sometimes slow due to system 
overload. Thus, it would be beneficial ifVirOligo could automatically process BLAST 
for PCR primers. 
In a BLAST for PCR primers system, the Oligo entry personnel enter primer 
sequences first. The system consists of two parts. First, the system sends each sequence 
and obtains the request ID (RID) for each sequence from NCBI. After sending all 
sequences, the system sends each RID and obtains BLAST result for each RID. The 
BLAST results are stored in MySQL database. The procedure has been programmed by 
Perl script, and has obtained 100 BLAST results in 5 minutes. 
Second, the system compares the BLAST results for primer pairs and shows 
users which GI numbers matched. Since the entry person has fewer lines to read in the 
results of BLAST for PCR primers and there is no need to compare several BLAST 
results, the work efficiency will be improved. Moreover, the entry person will not need 
to wait for BLAST processing, and the entry person keeps either entering the primer 
sequences or evaluating the result and creating the Oligo entries. 
Advertisement and Volunteer system, Email to authors 
Since the opening of the VirOligo database, no volunteer entry has been made yet 
by colleagues. The causes are probably insufficient advertisement of the database and 
that colleagues do not know that we need their entries. To announce our needs and the 
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database, we propose to send emails to authors of articles. The Advertisement and 
Volunteer System (AVS) will search newly added articles whose abstracts contain 'virus' 
and 'PCR' or 'oligonucleotide' from Current Contents (Institute of Scientific 
Information, Philadelphia). Current Contents will be chosen because not all PubMed 
abstracts contain email addresses of authors while Current Contents does. Since LMS 
manages all entries by PMID, A VS will search PMIDs in PubMed from article title and 
author names obtained from Current Contents, and store them in MySQL database to 
avoid resending the same request. A VS will send an email to the author with PMID, 
author names, article title and journal names, and ask the author to enter the 
oligonucleotide data in the VirOligo database. 
Linking with other databases 
We are currently exploring the possibility of linking our contents with 
International Committee on Taxonomy of Viruses (ICTV). Linking with other databases 
will be beneficial by increasing the traffic to the VirOligo database, thereby increasing 
the reputation ofVirOligo. NCBI also offers LinkOut to place direct links in PubMed, 
GenBank and Taxonomy database. The VirOligo database can be searched by PMID but 
not by GI or Taxonomy ID, so that, it would be necessary to add more search functions to 
the VirOligo database. After modification, we will prepare the files that NCBI requested. 
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Chapter 4: Application of the VirOligo Database for the ViSH Chip 
Method 
Results 
Total 480 influenza specific oligonucleotides, whose sequences were obtained 
from the VirOligo database and OMIGA primer design software, were synthesized and 
printed on microarray chips. Sequences of oligonucleotides are available in Appendix 1. 
Universal primers are specific to all segments of all influenza A viruses. Cy dye labeled 
PCR products were prepared as hybridization targets using universal primers and two 
equine influenza viruses, A/Equine/Kentucky/98 (KY98); A/Equine/Miami/63 (MI63), 
and three human influenza viruses, A/Hong Kong/68 (HK.68); A/New Jersey/76 (NJ76); 
A/Panama/99 (P AN99). After hybridizations with targets, the amount of products in 
association with each oligonucleotide probe was determined by measuring the 
fluorescence intensity using a fluorescence scanner (Scanarray 3000, Packard 
BioScience, Meriden, CT). A scanned image with a KY98 target is shown in Figure 4-1 
as an example. 
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Figure 4-1 , A scanned image sample of a ViSH chip with a KY98 target. 
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The amounts of hybridization for KY98 specific oligonucleotides were extracted 
from the scanned results by a data acquisition program, GenePix Pro 4 (Axon 
Instruments, Inc., Union City, CA). The extracted results contained intensities of 
hybridizations for thirteen oligonucleotides, whose sequences were obtained from the 
VirOligo database, fourteen oligonucleotides designed by OMIGA software, and two 
universal primers (Table 4-1 ). Negative values in the table indicate that the background 
intensity was stronger than the signal intensity. The range of theoretically possible 
intensities ranges from -65536 at no hybridization with very intense background to 
65536 at very intense hybridization without background. However, it is rare that the 
background is substantially more intense than the hybridization spot. Thus, the intensity 
values for no hybridization are close to zero. Spots of printed probes on the ViSH chip 
had diameters of approximately 150 µm and were spotted at four positions for each 
probe. When hybridization intensity was more than 1200, fluorescence scanner images 
showed clear circles in all four positions for most spots. At intensities under 1200, spots 
could not be recognized easily at all four positions. 
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Table 4-1 , Hybridization intensities of KY98 hemagglutinin segment specific probes and 
five targets, A/Equine/Kentucky/98 (KY98), A/Equine/Miami/63 (MI63), A/Hong 
Kong/68 (HK68), A/New Jersey/76 (NJ76), A/Panama/99 (PAN99). 
KY98 HK68 NJ76 PAN99 Ml63 
VirOligo database 
34 61549 26949 20468 
62 13308 7896 11376 13245 
82 3132 513 -173 
83 61341 3723 3143 
84 28380 8552 10360 
160 1338 104 833 20587 
181 9196 8394 10512 
197 92 2771 -157 
221 36546 17078 28609 
274 62313 8040 6956 
386 -1015 -515 -2848 -668 
486 1220 4291 348 236 
591 2367 426 6391 
OMIGA generated 
K1 1766 4823 5494 
K10 2751 5373 9140 2273 
K2 -517 28 -1831 
K3 23 185 -1251 
K4 -954 12 -1894 -184 
KS -650 181 -1455 
K51 -409 1 -1148 
K52 4542 3788 4668 17973 
K54 4644 48173 
K55 10458 48941 4519 
K56 1417 14757 1326 
K58 5552 15551 
K59 30820 63412 62067 
KS 3679 4213 2600 1446 
Universal Primers 
Uni5 
Uni3 
Note: From top, sequences for first thirteen probes were obtained from the VirOligo 
database. Next fourteen probes were obtained from a primer design program, OMIGA, 
and last two probes were universal probes. Shaded cells indicate the specificity to the 
targets. For example, Oligo 34 is specific to KY98 and MI63, and Uni5 is specific to all 
targets. 
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Since all probes in Table 4-1 were specific to the KY98 HA segment, appreciable 
levels of hybridization were expected for the probes when the KY98 target was used in 
the ViSH chip. However, the intensities of hybridization between KY98 specific probes 
and KY98 targets were distributed from -968 (Oligo 62) to 60895 (Oligo 34). The 
hybridization result was similar for the MI63 target. Nineteen KY98 specific probes 
were also specific to MI63 because both KY98 and MI63 are equine influenza viruses 
and H3N8 subtypes. The hybridization intensities ofMI63 specific probes with MI63 
target ranged from-217 (Oligo 82) to 64681 (Oligo K59), and the intensities were 
scattered widely. 
HK68, NJ76, and P AN99 targets were also tested for hybridization with KY98 
specific probes. BLAST analysis (BLASTn, NCBI; results obtained at expect value 100) 
revealed no sequence similarity between KY98 specific probes and HK68 targets. Since 
complete sequences of all HK68 segments are available at GenBank ·and no probes were 
specific to HK68, no hybridization should occur at the KY98 specific probes. The 
distribution of hybridization intensities was scattered and ranged from negative to more 
than 60000 with HK68 target. The results indicated non-specific binding of the targets to 
some of the KY98 probes. The results for hybridization for PAN99 and NJ76 targets 
were similar to the KY98 target and distributions of hybridization intensities were 
scattered. Only a partial sequence of the HA segments is available for PAN99, and no 
sequence of the HA segment is available for NJ76 at GenBank or the Influenza Sequence 
Database (http://www.flu.lanl.gov/). Thus, expected reactivity with the KY98 probes 
was known for neither PAN99 nor NJ76. However, non-specific binding of the targets 
was suspected for PAN99 and NJ76 since both are human viruses and no matches were 
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found with the partial sequence of P AN99 HA segment when pairwise BLAST searches 
(BLAST2, NCBI; results obtained at expect value 100) were performed with all KY98 
specific probes. 
The negative intensities with KY98 targets were not due to inappropriate 
hybridization temperature. Universal probes in Table 4-1 were 50 %(G+C) for Uni3 and 
33 %(G+C) for Uni5 and both 12 nt length. Because the universal primers were shorter 
than KY98 specific probes, which were at least 18 nt length, the universal primers had 
lower T ms than the KY98 specific probes. Two targets for Uni5 and one target for Uni3 
generated hybridization intensities of at least 2900, and the HK.68 target generated an 
intensity of22453 with Uni5. Thus, the universal probes were hybridized at the 
hybridization temperature used, and the hybridization temperature should be low enough 
for all probes. 
The universal probes were included in the array of the ViSH chips as standards. 
Targets were prepared by PCR. Amplification and labeling efficiencies, or PCR template 
concentrations vary in PCR, so that hybridization intensities in the scanning results 
probably differ among the targets due to differences in amounts of the labeled PCR 
products. Thus, the differences in the hybridization intensities due to the labeled PCR 
products need to be adjusted for comparisons of the hybridization intensities among 
targets. Since the universal probes were specific to all influenza A targets, the 
hybridization intensities in the universal probes were theoretically equal for all influenza 
A targets under the same experimental conditions. Adjustments of a ViSH result can be 
performed by calculating the coefficient to equalize the hybridization intensities in the 
universal probes between results for two targets, followed by multiplying all the 
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hybridization intensities by the coefficient. In the ViSH results shown in Table 4-1, the 
hybridization intensities of Uni3 and Uni5 were also scattered and some were negative 
values, even though both universal probes share the same sequences with all targets. 
Since the hybridization intensities contained negative values, the universal probes could 
not be used for standards. The sequences ofUni3 and Uni5 were similar. Only three 
nucleotides were different. Thus, the 5' end of the target may self-anneal to the 3' end of 
the same target strand when the target was amplified with these universal primers, and 
high intensity values may be due to hybridizations between Uni3 and Uni5. 
Even though the comparison of the hybridization intensities between targets is not 
appropriate due to variable target concentrations, some notable results can be seen in 
Table 4-1. The intensities for Oligo 3 86 were 34 72 for the KY98 target and negative for 
all others. An intensity value of 3472 is usually associated with a visually identifiable 
spot, and negative values indicate that the background level is more intense than the 
signal and no or a trace amount of hybridization was detected. Thus, it was possible to 
determine that Oligo 386 detected the KY98 target and differentiated it from other targets 
although the hybridization intensity was low. On the other hand, the hybridization 
intensity of Oligo 221 was 12293 with KY98 target, but all other targets generated higher 
intensities with values from 14142 to 36546. Thus, Oligo 221 hybridized with KY98 but 
did not differentiate it from other targets. 
Some probes, including Oligo 221 and 34, exhibited very high hybridization 
intensities while others had very low intensities. A correlation was sought between 
hybridization intensity and probe properties in length, Tm, %(G+C), target genome 
position, or number of mismatches. Thus, the correlations were examined (Table 4-2). 
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No significant correlation in probe length and hybridization intensity was found. For 
example, Oligo 62 was 19 nt long and generated a negative intensity but 20 nt (Oligo 34) 
and 18 nt (Oligo K52) probes generated intensities of more than 10000. Probes shorter or 
longer than 19 nt did not hybridize as poorly as 19 nt did. Additionally, no significant 
correlations were found between the hybridization intensity and target strand and region, 
Tm, or %(G+C). The first 17 nt of Oligo 82, 83, and 84 shared the same sequence. Oligo 
84 was a perfect match to the KY98 target, and Oligo 82 and 83 had mismatches to the 
KY98 target at their 3' ends. The hybridization intensities of Oligo 82, 83, and 84 were 
5664, 7146, and 5345, respectively, and no significant differe~ces in the intensity from 
the 3' end mismatches were found. Oligo 274 and 591 had 5' end mismatches to the 
KY98 target, and the hybridization intensities for both probes were more than 10000. 
Oligo 591 and K2 were perfect matches to the KY98 target but have an internal mismatch 
with the MI63 target. Since Oligo 591 had high intensity values (11170 for the KY98 
target and 21971 for the MI63 target) and Oligo K2 had low intensity values for both 
targets (70 for the KY98 target and -28 for the MI63 target), significant differences could 
not be observed between with and without an internal mismatch. Thus, no negative effect 
of mismatches on hybridization was found from mismatches on the ends and an internal 
mismatch. 
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Table 4-2, Probe lengths, Tms, %(G+C) contents, and genome and matched positions 
along with the hybridization intensities with the KY98 target. 
Genome position 
Intensity on Matched region on 
KY98 Len th Tm 0 c %G+C KY98 Strand KY98 M163 
From VirOligo 
34 60895 20 47.5 35.0 360-379 + PM 1-18 
62 -968 19 50.6 47.4 679-661 PM 
82 5664 24 56.8 41.7 1-17 + 1-17 1-17 
83 7146 22 55.0 45.5 1-17 + 1-17 1-17 
84 5345 25 58.3 44.0 1-25 + PM PM 
160 4748 20 58.5 60.0 843-824 PM 
181 9546 20 48.5 40.0 322-341 + PM 1-16 
197 11980 21 50.1 38.1 831-811 PM 5-21 
221 12293 24 54.1 41.7 9-32 + PM PM 
274 21756 20 56.7 55.0 1-17 + 4-20 4-20 
386 3472 19 44.1 31.6 208-226 + PM 
486 9103 20 54.6 55.0 286-305 + PM 
591 11170 20 56.8 55.0 847-831 4-20 1MM 
OMIGA generated 
K1 33143 19 49.0 47.4 71-89 + PM 3-19 
K10 5861 19 52.9 57.9 294-312 + PM 
K2 70 22 52.5 45.5 326-347 + PM 1MM 
K3 8899 18 47.0 44.4 72-89 + PM 2-18 
K4 21 19 49.0 4 7.4 363-381 + PM 
K5 1956 21 51.1 42.9 361-381 + PM 1-17 
K51 1358 18 47.5 44.4 539-522 PM PM 
K52 31268 18 51.2 55.6 753-736 PM 
K54 18993 18 48.2 50.0 764-747 PM PM 
K55 25110 20 51.3 50.0 766-747 PM PM 
K56 5296 19 49.5 47.4 765-747 PM PM 
K58 9565 22 56.5 50.0 768-747 PM PM 
K59 60396 21 56.4 57.1 760-740 PM 1-17 
K8 3815 21 57.5 57.1 292-312 + PM 
Universal Probes 
Uni5 516.5 12 21.7 33.3 5'end 
Uni3 -2405 12 31.9 50.0 3'end + 
Note: In matched region, PM stands for perfect match, and MM stands for mismatches in 
the middle of probe (lMM = one mismatches). Range of matched region is shown for 5' 
or 3' end mismatch. Tm was calculated by nearest-neighbor method (SantaLucia, 1998). 
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As Oligo 82, 83 and 84 shared the same region of the KY98 target, the target 
regions for Oligo K52, K54, K55, K56, K58 and K59 were also close to each other as 
shown in Table 4-3. When two nucleotides from the 5' end of K58 were removed, the 
hybridization intensities increased from 9565 (Oligo K58) to 25110 (Oligo K55). 
However, the hybridization intensities of probes that had three and four nucleotides 
removed from the 5' end ofK58 were 5296 (Oligo K56) and 18993 (Oligo K54), 
respectively. Since Oligo K54, K55, K56 and K58 contain the same sequence, the 
intensity value should be similar if there was no effect from 5' end sequences differences. 
However, the intensity values were scattered from 5296 to 25110. Thus, the differences 
in the intensities may be due to 5' end nucleotides. 
The sequence alignments of Oligo K51 to K59 did not suggest a cause of the 
variable hybridization intensities, but free energies of hairpins in Oligo K52 to K59 were 
a function of the hybridization intensities (Table 4-4; correlation coefficient, 0.943). No 
hairpin loop was predicted in Oligo K59 and the hybridization intensity was 60396. As 
the free energies of the hairpin loops decreased, the hybridization intensities declined. 
The hybridization intensity was 31268 (Oligo K52) at the free energy of the hairpin -0.91 
kcal/mol, 25110 (Oligo K55) and 18993 (Oligo K54) at -1.56 kcal/mol, and 9565 (Oligo 
K58) at-1.79 kcal/mol. Only the hybridization intensity of Oligo K56 did not follow the 
order of the free energies of the hairpin loops. Thus, all KY98 specific probes were 
examined to see whether the hairpin loops were correlated with the variable hybridization 
intensities (Table 4-5). However, no correlation was found between the hairpin free 
energies and the hybridization intensities for the entire set of KY98 specific probes 
(Correlation coefficient, 0.222). In addition to the hairpin, the free energies of dimer 
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formations and base compositions of the probe sequences were examined but no 
correlations were found with the hybridization intensities (Correlation coefficients, 0.117 
for dimer and -0.289 to 0.368 for base composition A to T). 
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Table 4-3, Sequence alignments along with the target regions and the hybridization 
intensities with the KY98 target. 
!Target Oligo 1Dregion Intensity Sequence 
K58 768-747 9565 TGCTTATCCTGCCTGATTGACC 
K55 766-747 25110 CTTATCCTGCCTGATTGACC 
K56 765-747 5296 TTATCCTGCCTGATTGACC 
K54 764-747 18993 TATCCTGCCTGATTGACC 
K59 760-740 60396 CTGCCTGATTGACCCCTAACC 
K52 753-736 31268 ATTGACCCCTAACCCACG 
Table 4-4, Comparison of free energies of hairpin loops and the hybridization intensities 
with the KY98 target. 
Hairpin 
Oli olD lntensit kcal/mol 
K59 60396 0 
K52 31268 -0.91 
K55 25110 -1.56 
K54 18993 -1.56 
K58 9565 -1.79 
K56 5296 -1.56 
Note: Free energies of hairpins were obtained from Oligo Analyzer 
(http://www.rnature.com/oligonucleotide.html) using nearest-neighbor method. 
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Table 4-5, Intensities with a fluorescent nucleic acid stain (SYTO 61), free energies of 
hairpin and dimer formations and base compositions of the probes along with the 
hybridization intensities with the KY98 target. 
Intensity Base composition 
Hairpin Dimer 
KY98 SYTO 61 kcal/mol kcal/mol A C G T 
From VirOligo 
34 60895 28749 -0.91 -4.2 7 5 2 6 
62 -968 26152 -2.76 -2.76 3 5 4 7 
82 5664 22043 -0.91 -1.79 12 3 7 2 
83 7146 29488 -2.76 -2.76 8 4 6 4 
84 5345 20711 -2.01 -2.01 8 4 7 6 
160 4748 18174 0 -9.89 5 7 5 3 
181 9546 14804 -0.91 -2.22 6 4 4 6 
197 11980 22883 -2.06 -7.19 6 5 3 7 
221 12293 9644 -2.01 -2.01 6 4 6 8 
274 21756 10460 -1.79 -3.08 8 4 7 1 
386 3472 18142 -3.06 -3.06 8 2 4 5 
486 9103 19088 -1.36 -4.24 5 6 5 4 
591 11170 11018 0 -9.89 4 6 5 5 
OMIGA generated 
K1 33143 23821 -0.96 -1.42 8 8 1 2 
K10 5861 12541 -0.96 -4.24 2 8 3 6 
K2 70 8886 -3.08 -3.08 8 5 5 4 
K3 8899 13968 -0.96 -1.42 8 7 1 2 
K4 21 10607 -0.91 -4.2 5 7 2 5 
KS 1956 12184 -0.91 -4.2 6 7 2 6 
K51 1358 12163 -0.91 -2.32 4 4 4 6 
K52 31268 13739 -0.91 -0.91 5 8 2 3 
K54 18993 17912 -1.56 -1.79 3 6 3 6 
K55 25110 16334 -1.56 -1.79 3 7 3 7 
K56 5296 15164 -1.56 -1.79 3 6 3 7 
K58 9565 12854 -1.79 -1.79 3 7 4 8 
K59 60396 15764 0 -1.79 4 9 3 5 
KS 3815 10660 -0.96 -4.24 3 9 3 6 
Universal Probes 
Uni5 516.5 11615 0 -0.96 7 1 3 1 
Uni3 -2405 11437 0 -1.79 6 2 4 0 
Note: Free energy of hairpin and dimer was obtained from Oligo Analyzer 
(http ://www.rnature.com/ oligonucleotide.html) using nearest-neighbor method. 
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All probes were printed at four positions, and the hybridization intensities of the 
four positions may be scattered due to variable qualities of the slide surface. Thus, 
maximum and minimum hybridization intensities of KY98 specific probes were 
examined (Table 4-6). Although the ratios of maximum to minimum intensities were 
spread wider with probes with low hybridization intensities than with those with high 
intensities due to noise in the scanning image, the maximum difference between the 
maximum and the minimum intensities was 7931 (Oligo 274), and the scattered 
hybridization intensities of the KY98 specific probes could not be accounted for by this 
variation. Thus, the variation in intensities was not due to a poor quality of slide 
surfaces. 
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Table 4-6, The hybridization intensities of the KY98 specific probes and the KY98 target. 
!Median Max Min Min/Max 
VirOligo database 
34 60895 61428 56159 0.91 
62 -968 -752 -2037 2.71 
82 5664 7182 1842 0.26 
83 7146 7700 2308 0.30 
84 5345 7426 1559 0.21 
160 4748 6385 2640 0.41 
181 9546 13745 5937 0.43 
197 11980 15230 8586 0.56 
221 12293 16445 11170 0.68 
274 21756 24374 16443 0.67 
386 3472 4198 122 0.03 
486 9103 9412 8119 0.86 
591 11170 11787 10612 0.90 
OMIGA generated 
K1 33143 33783 29190 0.86 
K10 5861 6975 4769 0.68 
K2 70 966 -530 -0.55 
K3 8899 10582 7503 0.71 
K4 21 412 -537 -1.30 
K5 1956 2520 719 0.29 
K51 1358 4497 797 0.18 
K52 31268 31908 28465 0.89 
K54 18993 19689 16736 0.85 
K55 25110 26946 21808 0.81 
K56 5296 5814 3580 0.62 
K58 9565 10553 8131 0.77 
K59 60396 61412 59681 0.97 
K8 3815 4499 2914 0.65 
Universal Primers 
Uni5 517 1121 -558 -0.50 
Uni3 -2405 -1846 -3373 1.83 
Note: All probes were printed at four positions. Maximums, minimums and medians of 
the hybridization intensities from four replicas were listed. 
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Discussion 
The purpose of the ViSH chip experiments was a comparison of probes obtained 
from VirOligo with those from a probe design program. However, the hybridization 
intensities for both groups of probes were scattered, and I could not determine a 
superiority of one method over another to obtain the probes for the ViSH chip. Thus, 
possible causes of the scattered intensities were examined in the Results. However, no 
significant facts to identify the cause were found in the analysis. 
Hybridization temperature was sufficiently low for hybridization of all probes, but 
some probes did not generate detectable levels of hybridization with the KY98 target. 
All probes were specific to KY98 HA segments and the presence of the HA segments in 
all PCR products used as targets was confirmed in gel electrophoretic images ( data not 
shown). All images contained 1.8 kb HA segments. Attachment of all probes on the chip 
was confirmed by a red fluorescent nucleic acid stain, SYTO 61 (Molecular Probes, Inc., 
Eugene, OR). Although the intensities with the stain for the KY98 probes varied up to 
3 .3 times, the intensities were not correlated with the hybridization intensities with the 
KY98 targets (Table 4-5). Thus, the causes of the scattered intensities were not due to 
the preparations of targets and printed slides. 
The intensities of Oligo K52 to K59 probes were related to the formations of the 
hairpins. Even though the relation was not supported by the entire KY98 specific probe 
set, hairpins may play a role in hybridization efficiency as observed in Oligo K52 to K59. 
Thus, probes with hairpins should be avoided. Array designer 2 (PREMIER Biosoft 
International, Palo Alto, CA) is a program to design probes for the oligonucleotide 
microarray, and the program selects probes with fewer hairpins and dimers within user-
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selected ranges of probe Tm and length. A similar algorithm was used in OligoArray 
(Rouillard et al., 2002). 
Another approach for probe selection in oligonucleotide microarray was 
introduced by Lockhart et aL, (1996) and Relogio et al., (2002). The probe selection 
program using their approach was created by Shteynberg (the program, Featurama, is 
available at http://probepicker.sourceforge.net/; pages viewed on Aug. 16, 2002). In this 
approach, probes were excluded if the numbers of (A+T) or (C+G), the number of single-
base repeats or the number of hairpins was exceeded. No KY98 specific probes were 
excluded by the standards for single-base repeat and hairpins set by Lockhart et al., 
(1996) and Relogio et al., (2002). Since the numbers of (A+T) or (C+G) were set for 20 
nt (Lockhart et al., 1996) and 25-35 nt (Relogio et al., 2002), and the probes in the ViSH 
chip were 12 to 29 nt, the standards were not applicable to all the probes in the ViSH 
chip. Although the numbers of (A+T) or (C+G) correlate with %(G+C), no specific 
1,._~1 
%(G+C) contents were found to generate weak or strong hybridization intensities in the 
KY98 specific probes (Table 4-2). 
Cushman (Personal communication, 1999; University ofNevada at Reno) found 
that the hybridization buffer we used caused non-specific binding of targets with probes. 
Thus, the hybridization buffer may be a cause of hybridization between the KY98 
specific probes and non-KY98 targets. Stringency of slide washing steps may not be 
enough to remove non-specific binding from non-KY98 targets, or too stringent and 
remove target specific probes from KY98 and MI63 targets. However, the binding 
strength between targets and probes is a function of the probe Tms. Since correlations 
between Tm and the hybridization intensity were not found in all targets, the stringency of 
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washing cannot explain why only some probes generated very low or negative 
hybridization intensities. 
The aldehyde slide (Catalog ID: ALS-25) was used in the experiments. The slides 
were purchased from TeleChem International, Inc. The company offers two qualities of 
the aldehyde slides, the ones used in these experiments cost $40 per 25 slides and the 
others cost $250 per 25 slides (Catalog ID: SMABC). The ViSH chip methods were 
initiated in my MS thesis (Onodera, 1999). At that time, an array-printing machine 
(arrayer) was not used, and each probe was spotted manually by a pipette. Thus, each 
manually spotted area was considerably larger than arrayer-generated spots, and the 
quality of the slide was probably not important in such larger spots. The size of each spot 
in arrayer-generated slides had a diameter of 150 µm. When the spot is smaller, 
uniformity of the slide surface may affect the spot intensities. As mentioned in Results, 
maximum differences of the hybridization intensities were more than 7000, and the 
quality of slide surface may be one of the causes of the scattered intensities. 
The significant causes of the failure could not be determined by the analysis. 
Similar results were obtained by Wang, et al. (2002). They tried to detect human 
intestinal bacteria in fecal samples by oligonucleotide microarray hybridization using 
aldehyde slides. Ten out of sixty probes did not hybridize to the target for unknown 
reasons, and the hybridization intensities were scattered. Therefore, the results obtained 
in the ViSH chip were not anomalous nor due to experimental failure. I assume that 
complex interactions among the hairpin loops, the hybridization buffer and the slide 
surface quality may interfere with the analysis of the ViSH chip results. 
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Many problems on the ViSH chip were discussed, but there was one positive 
result. At least one probe (Oligo 386) with low hybridization intensity differentiated 
KY98 from other influenza viruses, and another probe with a high hybridization intensity 
(Oligo 221) did not differentiate KY98 from other influenza viruses at all. For detection 
of viral nucleic acids, for each probe one needs to identify whether the target hybridized 
to the probe based on the hybridization intensity. Thus, a threshold value of the 
fluorescence intensity needs to be determined for the virus detection. The finding 
indicated that using only one threshold of the hybridization intensity to define positive or 
negative in hybridization is not valid since the hybridization efficiency is different for" 
each probe. The oligonucleotide microarray experiments performed by Lie et al. (2001) 
also support the finding. In their study, universal probes were used to detect five closely 
related bacilli. The hybridization intensity to one probe was up to 11 times more intense 
than to another probe when the same Bacillus species were hybridized. Thus, each probe 
must be tested with positive (probe specific) targets, and the ViSH chip threshold value 
needs to be defined for each probe before testing an unknown target. 
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Chapter 5: Primer Design 
Results 
Primer lengths and G+C contents 
Primer length and G+C content are among the most mentioned considerations in 
PCR primer design. To examine the ranges of primer length and G+C content that are 
used the most frequently, 2,137 virus-specific PCR primers were obtained from VirOligo. 
Most of primers used for PCR were between 18 and 22 nt long (65.8 %; Figure 5-1). 
Primers were most frequently 20 nt long (30.4 %). Thus, accumulated practice suggests 
that, if possible, one should select primers from 18 to 22 nt long. Although some sources 
recommend using primers of 18 to 30 nt (Newton, 1995; McPherson, et al., 1991), 16 and 
17 nt long primers were used more frequently (Average 2. 7 % ) than primers between 27 
and 30 nt long (Average 1.3 %). Thus, 16 or 17 nt long primer can be used with pure 
template since increasing selectivity using longer primers is not necessary with pure viral 
PCRs. 
From 40 to 60 % is the generally recommended range for the G+C contents of 
PCR primers, and 78.0 % of PCR primers reported in the VirOligo database were in this 
range (Figure 5-2). The most frequent G+C content was 50 % (23.7 % of all primers). 
However, 22 % of primers have G+C contents outside of the range. BHV-1 specific 
primers have a different distribution of G+C contents (Figure 5-3). G+C contents of 65 
% are the most frequent (23.9 %) among 134 BHV-1 specific primers and their 
distribution of G+C contents differed significantly from that of the entire collection of 
oligonucleotides (t-test, p=2.6E-32). 
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Primer melting temperatures (TnJ 
PCR depends on the melting and reannealing characteristics of DNA. Since the 
distribution of G+C content for BHV-1 primers differed from that for the collection of all 
primers, the optimal Tm for PCR primers may be virus specific. Tm was calculated by the 
nearest-neighbor method (SantaLucia, 1998). To obtain the predicted Tm distribution of 
20 bp fragments from the entire BHV-1 genome, 135,382 sequences were obtained from 
the entire BHV-1 genome (GenBank Accession No. AJ004801) by sliding a 20 bp frame 
from the 5' end to the 3' end one nucleotide at a time. Total 134 BHV-1 specific PCR 
primers were obtained from the VirOligo database. If T ms of primers are not significant 
factors in PCR experiments, distributions of predicted T ms from the entire genome and 
from primers reported in VirOligo should be indistinguishable. The distribution of 
primer Tm between 30 and 62 °C was not significantly different by x2 test between those 
predicted from the entire BHV-1 genome (20 bp) and primers reported ( actual) in the 
VirOligo database (Figure 5-4; x2 test, p=0.083). x2 test value was low due to a spike at 
58 °C in Figure 5-4. There was another spike at 64 °C. The causes of these spikes are 
unknown. Figure 5-4 indicates that primers were selected without regard to Tm as long as 
the Tm was less than 64 °C in BHV amplifications, and oligonucleotides with Tm s of 66 
°C or more were less favored for PCR and such primers were used less frequently. 
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The Tm distribution of FMV specific primers was also tested. While The G+C 
content of BHV-1 genome is high at 72.4 %, the G+C content of the FMV genome is 
lower than that ofBHV-1 at 53.1 % (GenBankAccession No. AF377945). For FMV, 
7,794 sequences fragments of 20 bp size were obtained from the entire FMV genome for 
a distribution of predicted Tms, and compared with 120 FMV specific PCR primers 
reported in the VirOligo database. The Tm distributions of the predicted Tms from the 
entire FMV genome and from PCR primers in VirOligo database were similar except for 
one primer in the VirOligo database whose Tm was 70 °C. Its inclusion significantly 
changed the x2 test result (Figure 5-5; x2 test, p=0.484 when the 70 °C oligonucleotide 
was excluded). The predicted Tms for FMV were distributed at lower temperatures than 
for BHV -1, and even at higher Tm, the predicted T ms from the entire FMV genome and 
from primers in the VirOligo database were similar. 
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The% (G+C) content of the BVDV genome is 45.5 % (GenBank Accession No. 
AF22024 7 .1 ), which is lower than those of FMV or BHV genomes. The Tm distribution 
of BVDV specific primers was obtained from 225 BVDV specific primers by the same 
methods used for BHV and FMV. T ms lower than 50 °C were less frequent in PCR 
primers than expected in the BVDV genome, and Tms higher than 60 °C were more 
frequent in PCR primers than expected (Figure 5-6). Since the high frequencies of high 
Tm primers in BVDV contrasted with the results obtained from BHV, the compositions of 
high Tm primers were examined. The mean of primer lengths with 60 °C or more Tm was 
significantly longer than primer lengths with less than 60 °C Tm. (27.8 nt for 60 °C or 
more Tm and 20.3 nt for less than 60 °C Tm; t test, p=5.38E-12). Only 11.3 % of primers 
with 60 °C or more Tm were tailed primers. Means between long primers and 20 bp 
fragments from the BVDV genome are different since longer primers have higher T ms. 
Thus, the comparisons between long primers and 20 bp fragments from the genome are 
not meaningful and cannot indicate under or over-representations of primers Tms. Such 
long primers should not be taken into consideration when representation of primer T ms 
are obtained. 
The results with BHV-1 primers indicated less frequent high Tm primers ( at 66 °C 
or higher) and the results with BVDV indicated less frequent low Tm primers (at 50 °C or 
lower). Most FMV specific primers were Tms between 50 and 64 °C, and primers were 
not under-represented in that range (95.0 %). Therefore, primers should be selected with 
Tm between 52 and 64 °C inclusive. 
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The 3 ' end triplet of primer 
Along with the size and the G+C content of the primer, the 3' end triplet of a 
primer is also one of the considerations mentioned frequently in primer design. If the 3' 
end triplet does not affect PCR efficiency, all triplets at the 3' end should be distributed 
equally. Instead, the 3' end triplets were not uniformly distributed (Figure 5-7; x2 test, 
p=l .5E-39). The most popular triplet, AGG (3.27 %), was 7.8 times more frequently 
used than the least popular triplet, TTA (0.42 %). The mean and standard deviation (s.d.) 
for triplet distribution was 1.56 % and 0.63%, respectively. Most frequently reported 
triplets (frequency greater than mean plus s.d.) were of 11 types, AGG (3.27 %), TGG 
(2.95 %), CTG (2.85 %), TCC (2.76 %), ACC (2.76 %), CAG (2.71 %), AGC (2.57 %), 
TTC (2.48 %), GTG (2.48 %), CAC (2.38 %), and TGC (2.34 %). All but one of the 11 
triplets (TTC) had 2 Sand one W. Six of these 11 triplets were WSS sequences. 
Commercially available software, such as OMIGA (Accelrys, San Diego), searches 
primers with 3' WSS as the default setting. Consistent with this default, six out of eight 
possible combinations of WSS were in the top 11 types. However, two of eight WSS 
triplets, ACG (1.31 %) and TCG (1.08 %), were two to three times less frequently 
reported in the VirOligo database than other combinations ofWSS. WGC was popular 
and in the top 11 combinations, but the proportion of WCG was less than the average. 
The under-representation of WCG suggests a high frequency of failure of PCRs using 
oligonucleotides ending in WCG since commercial software includes selection for WSS 
in the default setting. Four of the top 11 triplets were SWS triplets. All top 16 reported 
triplets had a 3' end G or C. Thus, the results suggest the following recommendation: 2 S 
and l W at the 3' end of primers with S at the 3' end. TTS was also frequently reported, 
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and it was in the top 14 combinations, but TTA was the least reported triplet (0.42 %). 
The least frequently reported triplets (less than mean minus s.d.) were of 6 types, TTA 
(0.42 %), TAA (0.61 %), CGA (0.65 %), ATT (0.75 %), CGT (0.75 %), and GGG (0.84 
%). Two of the lowest six types contained CGW. As mentioned above, WCG was less 
frequently reported compared to other combinations ofWSS. Thus, CG with Tor A at 
the 3' end seems less favored for PCR probably due to a weak binding of the 3' end. 
Three out of the lowest six types were triplets devoid of G or C, WWW. The most 
frequently reported types in WWW combinations were AAA (1.45 %) and AAT (1.22 
% ). Thus, it is advisable not to select low G+C contents at the 3' end of PCR primers to 
reduce the chances of failure in PCR. 
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3 4 
When a triplet appears less frequently in a genome sequence, the triplet is 
generally used less frequently in primer sequences. Thus, the frequencies of the 3' end 
triplets of primers may be proportional to the frequencies of the triplets in virus genome 
sequences. Since the primer sequence data consisted of 134 BHV-1 primers, 23 7 BVDV 
primers and 121 FMV primers, these viruses were used to test whether genome 
compositions affected the 3' end triplet frequencies. Thus, triplet frequencies of the 
BHV-1 genome (GenBank Accession No. AJ004801) were subtracted from frequencies 
of 3' end triplets in BHV specific primers (Table 5-1 ). The same processes were 
performed for BVDV and FMV (GenBank Accession Nos. AF220247 and AF377945, 
respectively). Negative values indicate under-representation of triplets and thus those 
triplets were used less frequently in primers than in genome sequences. A value of zero 
indicates that the triplet's frequencies in a genome sequence and in primers as the 3' end 
triplet were equal. The ten most and least frequently used 3' end triplets, adjusted for 
triplet frequencies in BHV, BVDV and FMV genomes, are shown in Figure 5-8. Since 
the number of primer sequences were few compared to total number of combinations for 
triplets ( 64 combinations), adjusted triplet frequencies were rough references to 
determine the effects of genome compositions. Most of the ten most frequently used 3' 
end triplets were over-represented in genome sequences (Figure 5-8A), and most of the 
ten least frequently used 3' end triplets were under-represented in genome sequences 
(Figure 5-8B). Means of frequencies between top ten and least ten 3' end triplets were 
significantly different in all three viruses tested (t test, p=0.011 for BHV; p=0.008 for 
BVDV; p=0.04 7 for FMV). Thus, the results of 3' end triplet frequencies were not due to 
genome compositions. 
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Table 5-1, Comparison among adjusted triplet frequencies of entire primers and BHV; 
BVDV; FMV specific primers. 
All viruses BHV rimers BVDV rimers FMV rimers 
TTA -1.14 -0.29 -0.84 -0.78 
TA -0.95 -0.25 -1.73 -0.49 
CG -0.91 -1.39 -0.57 -1.29 
ATT -0.81 -0.31 -0.43 -0.93 
CGT -0.81 -1.79 0.76 0.45 
GGG -0.72 -2.37 -1.06 -1.23 
AT -0.63 -0.26 -1.33 -0.29 
TAT -0.63 -0.27 0.06 -0.42 
TTT -0.58 -0.11 0.58 -0.13 
CCT -0.53 -1.53 -0.13 -0.9 
CT -0.53 -0.43 -0.72 0.11 
GTT -0.53 -0.68 -0.76 -0.75 
GCG -0.49 -2.69 -0.36 0.48 
TCG -0.49 1.01 0.8 0.62 
AG -0.44 0.04 -1.63 -0.11 
CGC -0.44 -4.04 0.02 1.67 
CTT -0.44 1.26 0 -0.15 
TCT -0.39 -0.7 0.24 0.39 
AAT -0.35 -0.27 -1.91 0.06 
-0.35 0.72 -2.54 0.55 
-0.35 -2.46 0.09 -0.66 
-0.35 1.05 -0.44 -0.02 
CA -0.3 -0.78 -1.99 -0.93 
-0.3 -3.9 0.63 1.71 
-0.25 3.2 0.08 1.49 
TC -0.25 0.24 0.68 0.76 
TG -0.25 -0.6 -1.73 -1.66 
GT -0.21 1.61 -0.58 -0.88 
cc -0.16 0.79 2.29 -1.38 
-0.16 -1.44 -0.11 2.43 
-0.16 1.56 0.41 -1.41 
-0.11 0.04 -3.11 -2.2 
-0.11 0.8 -0.75 -0.84 
-0.07 -0.56 -0.56 0.73 
-0.07 0.37 2.47 -0.83 
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Table 5-1 (Cont.) 
All viruses BHV primers BVDV primers FMV primers 
GCC -0.07 -2.01 -0.01 -0.97 
TAG -0.07 1.09 2.43 -0.36 
AAG -0.02 2.1 -1.5 -2.l 
CCC -0.02 -0.88 2.26 -0.99 
GG -0.02 2.26 -1.14 1.37 
GAC 0.03 -0.22 -0.31 0.9 
GAT 0.03 0.92 -0.83 -0.34 
AGT 0.08 0.98 -0.35 -1.18 
GGC 0.08 -2.19 1.87 -0.04 
ATG 0.12 0.08 0.64 -0.62 
GAG 0.22 -1.11 0.73 -1.97 
TGT 0.22 ~0.71 0.34 -1.43 
CAT 0.26 0.85 -0.51 0.35 
AAC 0.31 0.85 -1.16 -2.14 
ATC 0.31 0.21 -0.38 2.32 
TTG 0.36 -0.87 -1.23 -0.33 
GTC 0.5 0.94 0.8 2.97 
CTC 0.54 0.45 0.91 -0.88 
TGC 0.78 1.59 0.49 -0.61 
CAC 0.82 0.82 -1.13 6.52 
GTG 0.92 0.64 1.69 4.74 
TTC 0.92 -0.06 0.04 -1.55 
AGC 1.01 0.1 3.18 1.14 
CAG 1.15 0.56 2.83 1.71 
ACC 1.2 3.31 -0.54 -0.81 
TCC 1.2 3.23 0.91 0.27 
CTG 1.29 0.93 -0.56 -0.36 
TGG 1.38 -0.24 1.43 0.52 
AGG 1.71 0.79 3.29 0.74 
Note: Data is sorted according to 3' end triplet frequencies. The adjusted 3' end triplet 
frequency values (All viruses) represent 3' end triplet frequencies(%) minus average. 
Values for BHV, BVDV and FMV specific primers represent 3' end triplet frequencies 
(%) minus triplet frequencies(%) in the genome sequences. Negative values in BHV, 
BVDV and FMV indicate under-representation of the triplets and positive values indicate 
over-representation of the triplets. 
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Figure 5-8, Comparison among adjusted triplet frequencies of all primers (ALL) and 
BHV; BVDV; FMV specific primers. The adjusted 3' end triplet frequency values for all 
primers represent 3' end triplet frequencies(%) minus average. Values for BHV, BVDV 
and FMV specific primers represent 3' end triplet frequencies (%) minus triplet 
frequencies(%) in the genome sequences. Negative values in BHV, BVDV and FMV 
indicate under-representation of the triplets and positive values indicate over-
representation of the triplets. 
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Product sizes 
There are certain limitations on the sizes of product that PCR can produce. As 
mentioned in the introduction, PCR products less than 100 bp are difficult to differentiate 
from primer dimers in agarose gel electrophoresis, and large PCR products are generally 
difficult to amplify. To examine the ranges of PCR product sizes used, the distribution of 
product sizes was obtained from the VirOligo database (Figure 5-9). The range of 
product sizes most frequently used was 200 to 299 bp (18.3%). Less than 100 bp was not 
used frequently, as expected (2.0 %). More than half of PCR products were less than 
500 bp (57.8 %), and 82.3 % were less than 1 kb. The primer design program called 
OMIGA (Accelrys, Inc. San Diego, CA) selects 400 to 800 bp product in its default 
setting, but 400 to 800 bp size products accounted for only 28.1 % of all primer-pairs in 
the VirOligo database. Thus, primer design programs may not select the best primer 
pairs in their default settings. 
Large PCR products of 5 kb or more in size accounted for 0.9 % of total PCR 
products. Some polymerases amplify long PCR products, and TaqPlus Long DNA 
polymerase (Stratagene, La Jolla, CA) can amplify up to 35 kb. However, the high 
proportion of larger PCR products was because many primer pairs were generated from 
sequences that were not in GenBank. When a primer target position in a genome 
sequence was not mentioned in the articles, NCBI BLAST was used to search for the 
target position. BLAST results may give wrong positions and thus the wrong PCR 
product size if the primers were designed from a sequence that is not registered in 
GenBank. 
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Figure 5-9, Distribution of product size for all primer pairs in the VirOligo database. 
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Conclusion 
Proper primer design is a key for successful PCR. Primer design programs may 
not select the best primers with their default settings since the properties of primers used 
in virus detection differed from those recommended. Based on our analysis of primers 
actually used in PCR of viral genomes, we make the following recommendations: a 
primer length of 20 nt should be selected if possible, and shorter primers (16 nt or more) 
may not need to be avoided in the amplification of pure viral templates. Primers should 
be selected with T ms between 52 and 64 °C. WSS or SWS at the 3' end is a good choice 
for PCR primers. However, CG in the 3' end triplet, WCG or CGW, should not be 
selected for primers. The PCR product size should be 100 to 500 bp or smaller size. By 
adding the above considerations into the design of primers, the success ratio of PCR 
design should be improved. 
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Chapter 6: Optimizing reaction conditions 
Results 
Range of each variable in PCR 
A PCR mixture uses many components, and each component may be a target for 
optimization. Because PCR experiments have many variables, it is not practical to 
optimize all PCR components. As mentioned in the introduction, PCR tutorials usually 
list all possible variables, but they do not identify which variables are more important 
than others. Selecting the essential variables helps to reduce optimization processes by 
optimizing only the most critical factors. Determining the range of each variable is also 
helpful for PCR optimization. Analysis of PCR conditions in the VirOligo database 
reveals the popular ranges of PCR conditions. The factors that usually are not optimized 
probably do not need to be optimized since most experiments obtain amplified products 
without optimization of such factors. In similar fashion, the ranges of the variables 
obtained from analysis of the VirOligo database are probably the ranges that need to be 
optimized. 
Annealing temperature (T cJ and time 
The distributions of T as and annealing times were acquired from 1070 PCR 
experiments registered in the VirOligo database to determine the range of Ta· 
Approximately 30 % of PCR experiments were performed at Ta 55 °C (29.3 %), and 
almost all PCR experiments used temperatures between 45 °C and 65 °C (91.8 %; Figure 
6-1). Many experiments selected Tas from multiples of five, and 65.2 % were 45, 50, 55, 
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60 or 65 °C as T as. For annealing time, 44.5 % of experiments used 60 seconds (Figure 
6-2). 23.5 % used 30 second and 15.0 % used 120 second annealing time. 
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Figure 6-1, Distribution of annealing temperatures for 1070 PCR experiments obtained 
from the VirOligo database. 
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Figure 6-2, Distribution of annealing times for 1070 PCR experiments obtained from the 
VirOligo database. 
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Denaturation temperature and time 
The distributions of denaturation temperatures and times were acquired from 1071 
PCR experiments in the VirOligo database. Most experiments used either 94 °C or 95 °C 
for denaturation (72.1 % and 20.2 %, respectively; Figure 6-3). For denaturation time, 
most experiments used either 30 seconds or 60 seconds (23.4 % and 58.3 %, respectively; 
Figure 6-A). 
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Figure 6-3, Distribution of denaturation temperatures for 1071 PCR experiments 
obtained from the VirOligo database. 
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Figure 6-4, Distribution of denaturation times for 1071 PCR experiments obtained from 
the VirOligo database. 
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Extension temperature and time 
The distributions of extension temperatures and times were acquired from 1062 
PCR experiments in the VirOligo database. Most experiments used 72 °C extension 
temperature (85.5 %; Figure 6-5). Some experiments used lower temperature because 
annealing and extension were performed at the same temperature. For extension time, 
97.5 % of experiments used three minutes or less (Figure 6-6), and 54.0 % used one 
minute or less. Many experiments used multiples of 30 seconds or 60 seconds as 
extension times. Extension time 60, 120 and 180 seconds were used in 67.3 % of 
experiments, and 86.l % used a time among 30, 60, 90, 120 and 180 seconds. 
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Figure 6-5, Distribution of extension temperatures for 1062 PCR experiments obtained 
from the VirOligo database. 
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Figure 6-6, Distribution of extension times for 1062 PCR experiments obtained from the 
VirOligo database. 
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Magnesium ion (M/+) concentration 
The distribution of Mg2+ concentrations was acquired from 64 7 PCR experiments 
in the VirOligo database (Figure 6-7). Most experiments used less than 3.25 mM Mg2+ 
(87.5 %), and 65.2 % of experiments used less than 2.25 mM Mg2+. Mg2+ concentration 
of 2.0 mM was less frequently used than that of 1.5 or 2.5 mM. Many experiments 
probably used 1.5 mM Mg2+ since it is the starting concentration of Mg2+ recommended 
by the Taq DNA polymerase manufacturer. Only when amplifications with 1.5 mM Mg2+ 
concentration were not satisfactory, were optimizations of Mg2+ concentration performed. 
If 2.0 mM Mg2+ is optimum for the PCR experiment, such an experiment probably 
produce PCR product using 1.5 mM Mg2+ since the difference between 1.5 mM and 2.0 
mM is probably small enough for PCR experiment. Thus, 1.5 mM Mg2+ may be 
satisfactory for experiments with Mg2+ optimum at 2.0 mM and optimizations were not 
performed. If 2.5 mM Mg2+ is optimum for the PCR experiment, such an experiment 
may not produce PCR product using 1.5 mM Mg2+. Thus, 1.5 mM Mg2+ may not 
produce PCR product, and therefore, optimizations were performed for such PCR 
experiments. 
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Figure 6-7, Distribution ofMg2+ concentrations in 647 PCR experiments obtained from 
the VirOligo database. The bottom histogram is a detail of the top histogram between 1.0 
and 3.0 mM Mg2+ concentration. 
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dNTP concentration 
The distribution of dNTP concentrations was acquired from 773 PCR experiments 
in the VirOligo database (Figure 6-8). Most experiments used dNTPs concentrations 
between 0.10 and 0.30 mM (75.4 %), and 61.1 % used concentrations between 0.11 and 
0.20 mM. The most frequent dNTP concentration was 0.20 mM (59.5 %). 
Primer concentration 
The distribution of primer concentrations was acquired from 510 PCR 
experiments in the VirOligo database (Figure 6-9). Primer concentrations were widely 
distributed in PCR experiments registered in the VirOligo database. While 62.2 % of 
experiments used primer concentrations between 0.11 and 1.0 µM, 5.9 %used 
concentrations between 11 and 100 µM. The four most frequent primer concentrations, 
0.2; 0.4; 0.5; 1.0 µM, were about equivalent in frequency (18.0 to 22.5 %). 
PCRBuffer 
PCR buffer usually consists ofKCl and Tris-HCl. Most of 487 PCR experiments 
in the VirOligo database used 10 mM KCl and 50 mM Tris-HCl (76.4% and 88.9 %, 
respectively). pHs of PCR buffers were acquired from 538 PCR experiments in the 
VirOligo database. Most experiments used pH 8.3 (63.8 %; Figure 6-10). 
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Figure 6-8, Distribution of dNTP concentrations in 773 PCR experiments obtained from 
the VirOligo database. The bottom histogram is a detail of the top histogram between 
0.10 and 0.30 mM dNTP concentration. 
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Figure 6-9, Distribution of primer concentrations in 510 PCR experiments obtained from 
the VirOligo database. The bottom histogram is a detail of the top histogram between 0.1 
and 1.0 µM primer concentration. 
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Figure 6-10, Distribution ofpHs in 536 PCR experiments obtained from the VirOligo 
database. 
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Polymerase 
Most of 863 experiments in the VirOligo database used Taq DNA polymerase 
(72.2 %; Figure 6-11 ). The ratio becomes 86.9 % when modified Taq polymerases (i.e. 
AmpliTaq) were included in above ratio. Next most popular polymerase was Tth 
polymerase (2.1 %). The distribution ofTaq DNA polymerase concentrations was 
acquired from 449 PCR experiments in the VirOligo database (Figure 6-12). Taq DNA 
polymerase concentration of 0.03 U/µL were used most frequently in the PCR mixtures 
(39.6 %), and 81.1 % used between 0.01 and 0.05 U/µL. 
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Figure 6-11, Usage of thermostable polymerases in 863 PCR experiments obtained from 
the VirOligo database. 
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Figure 6-12, Distribution ofTaq polymerase concentrations in 449 PCR experiments 
obtained from the VirOligo database. 
103 
Correlations among PCR conditions 
While denaturation temperature and time, extension temperature, dNTP 
concentration, PCR buffer, thermo-stable polymerase and Taq polymerase concentration 
were the same or similar in most experiments in the VirOligo database, annealing 
temperature and time, extension time, Mg2+ concentration and primer concentration 
varied considerably. The variables that showed little variation cannot be used for 
correlation with other conditions. Thus, correlations among the more variable factors, 
annealing temperature and time; extension time; Mg2+ concentration; and primer 
concentration, were analyzed. 
Primer concentration 
Using the distribution of the primer concentrations (Figure 6-9) as a guide, the 
primer concentrations in 510 samples were divided into three ranges, 0.3 µM or less (A); 
more than 0.3 and less than 1.5 µM (B); 1.5 µMor more (C). For each range of primer 
concentrations, means of primer concentration and product Tm, Ta and Mg2+ 
concentration were obtained. The mean of Ta in the range C was 55.0 °C and it was 
significantly higher than the means of the ranges A (52.8 °C) and B (53.2 °C) using t tests 
(Table 6-1). The mean of product Tm in the range A was 88.3 °C and it was also 
significantly higher than the means of the ranges B (87.6 °C) and C (87.2 °C) using t tests 
(Table 6-1 ). Thus, primers in PCR experiments at higher primer concentrations had 
higher mean T as and lower mean of product Tm although the differences in Tm and Ta 
between primer concentration ranges were small. No significant differences were 
104 
observed by t tests between primer concentrations and the means of primer Tm or Mg2+ 
concentrations (Table 6-1 ). 
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Table 6-1, Effects of primer concentration on PCR conditions and results (p value) of 
statistical tests. 
Product Tm 
Primer Concentration :S0.3 M 0.3-1.5 µM ~1.5 M 
No. of Samples 149 236 134 
Median 88.0 87.8 87.4 
Mean 88.3 87.6 87.2 
:S0.3 vs 0.3-1.5 0.3-1.5 vs 2:1.5 :S0.3 vs 2:1.5 
0.048 0.335 0.006 
0.169 0.074 0.669 
Primer Tm (less stable primer) 
Primer Concentratio :S0.3 M 0.3 -1.5 M ~ 1.5 M 
No. of Samples 166 203 123 
Median 54.l 54.2 54.3 
Mean 54.3 54.6 54.7 
:S0.3 vs 0.3-1.5 0.3-1.5 vs 2:1.5 :S0.3 vs 2:1.5 
0.639 0.932 0.623 
0.044 0.952 0.083 
Primer Tm (more stable rimer) 
Primer Concentration :so.3 M 0.3 -1.5 M ~1.5 µM 
No. of Samples 158 206 129 
Media 55.l 54.7 54.3 
55.2 55.0 54.5 
:S0.3 vs 0.3-1.5 0.3-1.5 vs 2:1.5 :S0.3 vs 2:1.5 
0.723 0.469 0.300 
0.266 0.165 0.738 
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Table 6-1 (Cont.) 
Ta 
Primer Concentration :50.3 M 0.3 -1.5 M ~ 1.5 M 
No. of Samples 165 223 130 
Median 55.0 55.0 55.0 
Mean 52.8 53.2 55.0 
:50.3 vs 0.3-1.5 0.3-1.5 vs 2:1.5 :'.S0.3 vs 2:1.5 
0.471 0.005 < 0.001 
0.434 0.160 0.516 
Mg2+ concentration 
Primer Concentratio <0.3 µM 0.3 - 1.5 M > 1.5 µM 
No. of Samples 147 196 124 
Median 1.50 1.50 1.75 
Mean 2.33 2.11 9.37 
:'.S0.3 vs 0.3-1.5 0.3-1.5 vs 2:1.5 :'.S0.3 vs 2:1.5 
0.226 0.273 0.288 
0.004 < 0.001 < 0.001 
Note: Three ranges, 0.3 µMor less (:'.S0.3 µM); 0.3 µMor more and 1.5 µMor less (0.3-
1.5); 1.5 µMor more (2:1.5 µM), were compared by F test. When p value of F test was 
bigger than 0.05, "t-Test: Two-Sample Assuming Equal Variances" were used. When p 
value was 0.05 or less, "t-Test: Two-Sample Assuming Unequal Variances" were used. 
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Mg2+ concentration 
Using the distribution of the Mg2+ concentration (Figure 6-7) as a guide, the Mg2+ 
concentrations in 647 samples were divided into two ranges, 1.5 mM or less (A) and 
more than 1.5 mM (B): For both ranges of the Mg2+ concentrations, means of primer Tm, 
product Tm and Ta were obtained. 324 entries were in the range A and 323 entries were 
in the range B. lfMg2+ concentration affects Tm or Ta in PCR experiments, the means 
should be significantly different between the ranges. However, the results in two groups 
ofMg2+ concentrations were not significantly different in primer Tm, product Tm and Ta (t 
test; Table 6-2). 
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Table 6-2, t test results (p value) and comparisons between Mg2+ concentrations 1.5 mM 
or less (:S:1.5 mM) and more than 1.5 mM (> 1.5 mM) for mean Ta, primer Tm and product 
Tm. 
Mean (°C) p value 
M + concentration ::; 1.5 mM > 1.5 mM t test 
Tm of Less Stable Primers 54.9 55.5 0.202 
Tm of More Stable Primer 56.7 57.4 0.143 
Tm of PCR Products 88.1 87.4 0.055 
Ta 54.1 54.4 0.661 
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Additives 
Gelatin and BSA were sometimes added in PCR mixtures to stabilize polymerase. 
Both were observed in PCR experiments registered in the VirOligo database. Gelatin and 
BSA were used in 9.7 % and 4.4 % of PCR experiments, respectively. However, the 
usages of gelatin and BSA were probably more frequent than those percentages since 
some PCR buffers contain gelatin (e.g. Applied Biosystems, Foster city, CA) or BSA 
(e.g. Fermentas, Inc., Hanover, MD), and most PCR experiments did not list all 
components of PCR buffers. Since it could not be determined which PCR experiments 
truly lacked gelatin or BSA, correlations among PCR conditions with and without gelatin 
or BSA were not analyzed. 
DMSO was the only additive found in the VirOligo database not usually 
contained in PCR buffers or polymerase storage buffers. DMSO were used in 34 PCR 
experiments. Of these 27 experiments were for amplification ofherpesvirus, and 11 
PCRs were for BHV-1. DMSO is used for amplification of templates with high% (G+C) 
contents. Since the VirOligo database contained 48 PCR experiments amplifing BHV-1 
with a clear description of the buffer used, the 11 PCR experiments with DMSO 
represented only 23 % of total BHV-1 amplification experiments. The differences in 
PCR conditions with and without DMSO were tested. There were no significant 
differences found among product %(G+C), product size, product Tm, primer Tm, Mg2+ 
concentration, primer concentration, denaturation time, extension temperature, extension 
time, Ta or annealing time (Table 6-3). Means of denaturation temperature were 
significantly different between with and without DMSO (t test, p = 0.0048), but the 
difference between the means was only 0.6 °C. 
110 
Table 6-3, Effects ofDMSO on PCR conditions and results (p value) of statistical tests. 
More Less 
stable stable Mg2+ Primer 
Product Product Product primer primer cone. cone. 
Mean %(G+C) size (bp) Tm Tm Tm mM) (microM) 
wlDMSO 68.0 378.0 96.3 61.2 54.4 2.2 1.0 
wlo 
DMSO 71.1 455.4 97.1 60.6 60.5 1.6 0.7 
p value 
t test 0.077 0.351 0.216 0.704 0.245 0.054 NIA 
F test 0.084 < 0.001 0.080 0.413 < 0.001 0.142 NIA 
Denaturation Denaturation Extension Extension Annealing 
Mean temp time tern time Ta time 
wlDMSO 94.3 49.1 72.2 60.0 57.4 60.0 
wlo 
DMSO 94.9 57.2 72.1 85.9 59.1 62.8 
p value 
t test 0.005 0.363 0.690 NIA 0.357 NIA 
F test 0.166' < 0.001 0.468 NIA 0.540 NIA 
Note: Means of PCR conditions were compared between with and without DMSO. 
When p value of F test was bigger than 0.05, "t-Test: Two-Sample Assuming Equal 
Variances" were used. When p value was 0.05 or less, "t-Test: Two-Sample Assuming 
Unequal Variances" were used. 
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Extension time 
During the extension step in a PCR cycle, PCR products are elongated. Longer 
extension times allow polymerase to produce larger PCR products. Since 86.1 % of 
experiments used 30, 60, 90, 120 or 180 seconds as mentioned above, means of product 
size and product Tm were obtained to compare the effect of extension time (Table 6-4). 
Both 30 and 60 second extensions had similar means of product sizes (t test, p = 0.45). 
Extension times among 90, 120, and 180 second had similar means of product sizes, too 
(t tests, p = 0.25 for between 90 and 120 seconds; p = 0.85 for between 120 and 180 
seconds). The means of product sizes were 0.4 kb for 30 and 60 seconds, and 0.7 to 0.8 
kb for 90, 120 and 180 seconds. Thus, extension time was either 60 seconds or less or 
more than 60 seconds based on product size. No significant differences were found in the 
means of product Tm (t tests; Table 6-4). 
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Table 6-4, Effects of extension time on PCR conditions and results (p value) of statistical 
tests. Means of product sizes and Tm were obtained. Product sizes and Tm compared by 
F test. When p value ofF test was bigger than 0.05, "t-Test: Two-Sample Assuming 
Equal Variances" were used. When p value was 0.05 or less, "t-Test: Two-Sample 
Assuming Unequal Variances" were used. 
Extension time (sec)! Product size (bp) Product Tm (°C) No. of samples 
Product size 
30 
60 
90 
120 
180 
I 30 sec vs. 60 sec 
t test 0.454 
F test 0.455 
Product Tm 
t test 
F test 
I 30 sec vs. 60 sec 
0.404 
< 0.001 
422.0 
459.2 
831.7 
727.1 
742.9 
87.7 
88.0 
87.8 
87.8 
87.5 
96 
364 
103 
172 
173 
60 sec vs. 90 sec 90 sec vs. 120 sec 120 sec vs. 180 sec 
< 0.001 0.250 0.850 
< 0.001 < 0.001 0.834 
60 sec vs. 90 sec 90 sec vs. 120 sec 120 sec vs. 180 sec 
0.654 0.945 0.288 
0.051 0.496 0.021 
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Annealing time 
Annealing time was 2 minutes or less in most experiments. Annealing time may 
correlate with annealing temperature since both affect annealing between template and 
PCR primer. Thus, correlation coefficient between annealing time and Ta was 
determined. Additionally, correlation coefficients between annealing time and product 
%(G+C), product size, product Tm or primer Tm were obtained. Ta and annealing time 
were not significantly correlated, but they were the most correlated of all parameters 
checked ( correlation coefficient, -0.18; Table 6-5). The correlation between Ta and 
annealing time was examined further. The means of Ta were obtained for four categories 
of annealing time, 30 seconds or less; 60 seconds; 90 seconds; 120 seconds. Based on t 
test results, the mean of Ta in the category of 120 seconds was significantly lower than 
means in the other three categories by 3 to 5 °C (Table 6-6). The differences in Ta were 
small compared to the Ta distribution of 37 to 65 °C. 
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Table 6-5, Correlation coefficients between annealing time and other PCR conditions. 
More Less 
stable stable 
Product Product Product primer primer Annealing 
%(G+C) size Tm Tm Tm Ta time 
Annealing 
time -0.084 0.071 -0.032 -0.025 -0.066 -0.176 1 
Table 6-6, Effects of annealing time on PCR conditions and results (p value) of statistical 
tests. 
Annealing time (sec) Mean of Ta No. of sam~les 
30 orless 55.0 277 
60 54.1 479 
90 53.0 53 
120 50.4 160 
30 sec or less vs. 60 sec 60 sec vs. 90 sec 90 sec vs. 120 sec 
t tes 
F tes 
0.059 
< 0.001 
0.302 
0.198 
0.016 
0.935 
Note: Means of Ta were obtained and compared. When p value ofF test was bigger than 
0.05, "t-Test: Two-Sample Assuming Equal Variances" were used. When p value was 
0.05 or less, "t-Test: Two-Sample Assuming Unequal Variances" were used. 
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Annealing temperature (Ta) 
An estimation of Ta has been attempted (Newton and Graham, 1997; Sambrook 
and Russell, 2001; Dieffenbach, et al., 1993; Kidd and Ruano, 1995; Wetmur, 1991). 
Those attempts use only the Tm of primers or Tm of primers and product to estimate Ta· 
Thus, the correlation between Ta and the Tm of products or primers was tested for 64 7 
PCR experiments registered in the VirOligo database. Ta did not correlate well with 
product Tm ( correlation coefficient, 0.15). The correlations between Ta and primer Tm 
were more than between Ta and product Tm (correlation coefficients were 0.26 for less 
stable primers and 0.19 for more stable primers), but these were still not significantly 
correlated. 
A certain range of Ta can be used to amplify the PCR product. Usage of a low Ta 
increases chances of artifacts and non-specific bindings of primers. One of the causes of 
artifacts and non-specific bindings is often contamination in templates. Thus, an 
estimation of the minimum Ta (Tamin) can be affected by template purity. A usage of 
low Ta also lengthens the total PCR time due to ramping times in a thermal cycler, and 
longer PCR time lowers polymerase activity. Thus, Tamin is affected by the performance 
of a thermal cycler and the polymerase. While it is probably difficult to estimate the 
Tamin due to involvement of many factors, the maximum Ta (T amax) may possibly be 
estimated since annealing and melting are closely related and Tm can be calculated. An 
estimation of T amax is useful since artifacts can be avoided by using the highest Ta still 
compatible with amplification. Thus, primer Tm and Ta were compared in scatter graphs. 
Dots in the scatter graphs formed roughly quadrilateral shapes (Figure 6-13A for Tm of 
less stable primer and Figure 6-13B for Tm of more stable primer). Since both 
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distributions had similar shapes and the Tm of the less stable primer had a higher 
correlation coefficient than the Tm of the more stable primer, the graph for Tm of the less 
stable primer and Ta was used to obtain T amax. T ms rounded to the nearest five °C, and 
T as at 95 percentile were calculated for primer T ms, which have at least ten T as. Then, a 
regression line was obtained from those T as at 95 percentile and primer Tm· The line 
deduced was Tamax ( °C)=l.2x[Tm ofless stable primer] when Tm was between 35 and 
55 °C. Primers with Tms of 55 °C or more reached maximum Tamax of 65 °C since 
higher Ta made it difficult for primers to hybridize to template due to active melting of 
hybrids. 
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Figure 6-13, Scatter diagrams of Ta reported in the VirOligo database against less stable 
primers (A), and more stable primers (B). An oblique line shown in Fig. A indicates 
maximum Ta(Tamax) against Tm ofless stable primer. Three sizes of spots in the 
diagrams are used according to the number of dots at the given X-Y coordinates. 
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Confirmation of the relationship between Tm of primer and Ta 
An equation to estimate Tamax was suggested above. To test the suggested 
equation in actual experiments, ten primer pairs (Table 6-7) that are specific to equine 
influenza virus (GenBank Accession number: AF197241) were designed by a PCR 
primer design program, OMIGA (Accelrys, San Diego). Twelve T as between 42 and 66 
~C for primer pairs 1-7, or 48 and 72 °C for primer pairs 8-10 were tested in PCR 
experiments. Then, the ranges of Ta that generated PCR products were identified by gel 
electrophoresis (Figure 6-14). Actual T3maxs for all the ten primer pairs were slightly 
higher than estimated Tamaxs by 0.4 to 4.6 °C (Table 6-8 and Figure 6-15). This was 
probably because the equation was deduced from analysis of published PCR conditions, 
which may not all have been using T amax. Thus, it is reasonable that all actual T amaxs 
were higher than estimated T amaxs. As seen in the gel electrophoresis results of PCR 
experiments (Figure 6-14 ), most PCR experiments performed at the actual T 3max 
produced less PCR products than experiments with lower Ta· Therefore, it is best to 
select Ta without exceeding the estimated T amax. 
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Table 6-7, PCR primers. 
Primer 
Pair Sequence Tm{°C) Genome Position 
1 CTACAGTCAAAACCCAACC 49.0 71-539 
TGTTAGCCAATTCAGTCG 47.5 
2 GGACCTCTTCATAGAAAGAAGC 52.5 236-753 
ATTGACCCCTAACCCACG 51.2 
3 TACAGTCAAAACCCAACC 47.0 72-539 
TGTTAGCCAATTCAGTCG 47.5 
4 TGCTACCCATATGACATCC 49.0 363-764 
TATCCTGCCTGATTGACC 48.2 
5 ATTGCTACCCATATGACATCC 51.1 361-766 
CTTATCCTGCCTGATTGACC 51.3 
6 TGCTACCCATATGACATCC 49.0 363-765 
TTATCCTGCCTGATTGACC 49.5 
7 ATTGCTACCCATATGACATCC 51.1 361-765 
TTATCCTGCCTGATTGACC 49.5 
8 ACCCCCACTGTGATGTCTTCC 57.5 292-768 
TGCTTATCCTGCCTGATTGACC 56.5 
9 ACCCCCACTGTGATGTCTTCC 57.5 292-760 
CTGCCTGATTGACCCCTAACC 56.4 
10 CCCCACTGTGATGTCTTCC 52.9 294-766 
CTTATCCTGCCTGATTGACC 51.3 
Note: Total fourteen primers were in ten primer-pairs. Some primers were used more 
than once. Genome positions were based on GenBank® accession no. AF197241.1. 
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Figure 6-14, PCR results with ten primer pairs for amplification of an equine influenza 
virus. Twelve annealing temperatures were tested for each primer pair. Lane 
assignments for primer pair 1 to 7 were lanes 1 and 14, 100 bp ladder; lane 2, 66.0 °C; 
lane 3, 65.4 °C; lane 4, 64.0 °C; lane 5, 62.1 °C; lane 6, 59.4 °C; lane 7, 56.0 °C; lane 8, 
52.0 °C; lane 9, 48.5 °C; lane 10, 45 .8 °C; lane 11 , 43 .8 °C; lane 12, 42.6 °C; lane 13, 42.0 
°C. Lane assignments for primer pair 8 to 10 were lanes 1 and 14, 100 bp ladder; lane 2, 
72.0 °C; lane 3, 71.5 °C; lane 4, 70.0 °C; lane 5, 68.1 °C; lane 6, 65.4 °C; lane 7, 62.0 °C; 
lane 8, 58.0 °C; lane 9, 54.6 °C; lane 10, 41.8 °C; lane 11 , 49.8 °C; lane 12, 48.6 °C; lane 
13, 48.0 °C. 
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Table 6-8, Actual Tamaxs and estimated Tamaxs for ten primer pairs. 
Tm of more 
Actual T amax Tm of less stable stable primer Estimated 
Primer- air No. (OC) rimer (°C) (OC) Tamax (°C) 
1 59.4 49.0 47.5 57.0 
2 64.0 52.5 51.2 61.4 
3 59.4 47.0 47.5 57.0 
4 62.1 49.0 48.2 57.8 
5 64.0 51.1 51.3 61.6 
6 62.1 49.0 49.5 59.4 
7 64.0 51.1 49.5 59.4 
8 65.4 57.5 56.5 65.0 
9 65.4 57.5 56.4 65.0 
10 62.0 52.9 51.3 61.6 
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Figure 6-15, Actual T amaxs obtained for ten primer-pairs and estimated T amaxs against 
Tm of less stable primers. Those are overlaid on Fig. 6- l 3A with more than three dots in 
X-Y coordinates (VirOligo data). 
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Discussion 
Since many variables exist and each variable interacts with other factors, the 
possible combinations of PCR conditions may exceed hundreds. However, only several 
factors were optimized in most PCR experiments. 
One of the notable facts was high usage ofTaq polymerase (86.9 %). The second 
most popular polymerase in the VirOligo database was Tth, but only 2.1 % of 
experiments used Tth, which was first used in 1991 (Myers and Gelfand, 1991). One 
quarter (24.9 %) of the PCR experiments used for the analysis were published after 
January 2000. Thus, high usages ofTaq polymerase were not due to the age of the 
analyzed data, and Taq polymerase is simply still very popular even though so many 
polymerases are available on the market. 
Denaturation temperature and time, extension temperature, dNTP concentration, 
polymerase and PCR buffer, were not adjusted in most experiments, as expected. The 
purpose of the denaturation in a PCR cycle is complete separation of double strands. 
Higher temperature and longer time are better for denaturation. However, the 
temperature and time are limited by half-life of the polymerase. Since most experiments 
used Taq polymerase, it is not surprising that most experiments used similar denaturation 
temperatures and times. Extension temperature depends on the temperature at which the 
polymerase has the best activity. PCR buffers are provided by polymerase manufactures. 
These buffers are mostly the same, and according to Promega, the buffer is optimized for 
0.2 mM each dNTP. Thus, it is expected that most experiments did not adjust PCR 
buffer and dNTP concentration. 
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Annealing temperature (Ta) and time, extension time, Mg2+ concentration and 
primer concentration were variable factors. Although optimum Mg2+ concentration could 
not be estimated, 1.5 mM and 2.5 mM Mg2+ concentrations were found to be exclusively 
used in PCR experiments. Annealing and extension times were weakly correlated with 
Ta and product size, respectively. However, those distributions were significantly 
different only at one dividing point, between 90 seconds or less and 120 seconds or more 
for annealing time; between 60 seconds or less and 90 seconds or more for extension 
time. For example, no significant difference in Ta was found between 30 second 
annealing and 60 second annealing or between 90 second annealing and 120 second 
annealing. Since no continuous differences were found statistically among the 
distributions in 30, 60, 90 and 120 second annealing or extension, researchers may 
choose longer annealing or extension times when Ta is lower or the PCR product is larger 
even though longer annealing or extension times are actually not necessary for the PCR 
experiments. Extension rate for Taq polymerase is 2 to 4 kb per minute (Qiagen Inc., 
Valencia, CA). Thus, one-minute extension may be sufficient for most experiments. 
Primer concentration was correlated with Ta and product Tm· When primer 
concentration was high, Ta was high and product Tm was low. Although mechanisms that 
could account for correlation between primer concentration and product Tm are not 
known, the correlation between primer concentration and Ta is explainable. When higher 
Ta is used in the PCR experiment, a lower percentage of primers anneals to templates. 
Thus, a higher concentration of primers in PCR mixture is required when a higher Ta is 
used. However, the effects of primer concentration are not worth considering during 
planning PCR experiments since the differences in means of Ta and product Tm were no 
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more than 2. 7 °C and 1.3 °C, respectively, when various primer concentrations were 
used. 
The T 3max estimation equations were deduced from the PCR experimental data in 
the VirOligo database and confirmed in actual PCR experiments with ten primer pairs. 
Since higher Ta can reduce non-specific products (Sambrook and Russell, 2001 ), the 
T amax estimation equations are useful, and Ta should be selected within estimated T 3max. 
Many variables exist in PCR experiments, but factors that need to be optimized in 
most PCR experiments were only Mg2+ concentration and Ta· Estimation methods for the 
best Ta was suggested above and either 1.5 mM or 2.5 mM MgClz was sufficient for most 
PCR experiments. 
Recent developments of microarray technology and SNPs (Lashkari, et al., 1997; 
Buetow, et al., 2001) sometimes require preparations of thousands of PCR experiments. 
When a large number of PCR experiments are conducted, reductions of optimization 
steps are critical to reduce cost and labor as well as consumption of PCR templates. 
Therefore, the suggestions made from the analysis results will help such large scale PCR 
experiments. 
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Chapter 7: Conclusion 
The aim of this study was preparing the fundamentals for the implementation of 
the universal virus detection system. The proposed methods of the universal virus 
detection system were ViSA card and ViSH chip methods. Those methods were first 
tested in my M.S. research. Then, this study was conducted for further development of 
ViSA card and ViSH chip methods. Thus, this study is a second step towards the 
universal detection system. 
Construction of the VirOligo database was useful for the ViSA card and ViSH 
chip methods in three ways. First, VirOligo can help provide virus specific 
oligonucleotide sequences for use in both methods. Second, analysis of oligonucleotides 
in VirOligo can provide methods to design oligonucleotides for use in the methods. 
Third, analysis of reaction conditions of PCR experiments can help reduce the 
optimization processes of the Vi SA card method. 
Analysis of oligonucleotides revealed that oligonucleotide design programs were 
not always selecting the best oligonucleotides. Thus, VirOligo was an appropriate 
method to collect the oligonucleotides from journal articles for ViSA card and ViSH chip 
though the oligonucleotide sequences from VirOligo showed unexpected behaviors in 
influenza detection. Requirements for hybridization probe design and primer design may 
be different, and ViSH chip needs hybridization probes instead of PCR primers. 
VirOligo is a database of virus specific oligonucleotides, but most oligonucleotides listed 
were PCR primers. Thus, further expansions ofVirOligo database collections may help 
ViSH chip. The expansion also helps analysis of hybridization probe requirements. 
126 
Recommendations for reaction conditions were proposed. Since ViSA card uses a 
number of primers, it is necessary to reduce optimization processes due to cost ofViSA 
cards and complex interactions of factors. Since ViSA card is a PCR based detection 
method, the recommendations will help optimization processes faster. Primers for ViSA 
card can be obtained from proposed primer design methods and the published primers in 
the VirOligo database. 
The universal virus detection systems, ViSA and ViSH, are under development. 
However, I believe that this study brings us one step closer to the realization of the 
system. The universal virus detection system is necessary to improve our public health 
by diagnosing virus infections from the patients with chronic disease; rapid detection of 
virus outbreaks under biological terrorism attacks; and testing for food or water 
contamination. Recent developments of microarray technologies also help giving life to 
the universal virus detection system. 
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Appendixes 
Appendix 1: Oligonucleotides Used in the ViSH Chip Experiments 
Oligo ID Sequence Length (nt) 
1 AAAAGCAGGGGATAATTCTATTAA 24 
3 AAACAAACATCCCTAAGAT 19 
4 AAACCAGCAATAGCTCCGAA 20 
5 AAACCGGCAATGGCTCCAAA 20 
8 AAAGCAGGGGAAAATAAAAACAACC 25 
9 AAAGCAGGTACTGATCCG 18 
10 AAATACGGTGGATTAAATAAAAGCAA 26 
11 AAATCATGGTCCTACATTGCAGAAA 25 
12 AAATGGTGCAGGCAATGAGAG 21 
13 AACATGCCCATCATCATTCCAG 22 
14 AACCCCTTATCGAACCCT 18 
15 AACGAGGGTATGTCCACTCC 20 
16 AACGGCATAATAACTGAAACC 21 
18 AAGCAGGGGATAATTCTATT 20 
19 AAGCATGGCTGCATGTTTGTG 21 
20 AAGGGCTTTCACCGAAGAGG 20 
21 AAGGGGTTTTCATACAGGTATGGT 24 
22 AAGGTCCTGCATTCCAAGTG 20 
23 AAGTGCACCAGCAGAATAACTGAG 24 
24 AATAGATGTAAGGCTTGCAT 20 
26 AATCCATCCACATAGGCT 18 
27 AATCTAATGTCGCAGTCTC 19 
28 AATCTTCTCAGAGGATATGA 20 
29 AATCTTCTCAGAGGATATGAA 21 
30 AATGATCGGAACTTCTGGAG 20 
31 AATGCTGCTCCCACTAGTCCAG 22 
34 AATTGCTACCCATATGACAT 20 
35 AATTTGCTATGGCTGACGGA 20 
36 AATTTTGATGCCTGAAACCGT 21 
37 ACAAATTGAGGTGGGTCCG 19 
133 
38 ACACTTCCAACCCAATTTGG 20 
39 ACAGACCCCTTACCCAGGGT 20 
40 ACAGATTGCTGATTCCCAGC 20 
41 ACATACAGTGGGATAAGAACC 21 
43 ACCAAAATGAAGGCAAACC -~ 1~ 
44 ACCAAGCAACCGATTCAAAC 20 
45 ACCAGCAATAGCTCCGAAGA 20 
46 ACCAGCAATAGCTCCGAAGAAACC 24 
47 ACCAGGATATCGAGGATAACAGGA 24 
48 ACCAGGCGATCATGGATAAA 20 
49 ACCAGGGTAGTCAAGGGCT 19 
50 ACCGCTGGGATACAAATCAG 20 
51 ACCGGCAATGGCTCCAAA 18 
53 ACCTTCGGCAAAAGCTTCAATACTCCA 27 
54 ACCTTGCATTAGAGAGCACA 20 
55 ACGCATTCCGACTCCTGG 18 
59 ACTATCATTGCTTTGAGC 18 
60 ACTCAAAACACCCATTTCCG 20 
61 ACTCCAATGGGGGCGATAAAC 21 
62 ACTCGTCCTGATTCTTGGA 19 
65 ACTGCAGCGTAGACGCTTTGTCC 23 
67 ACTGTTACCCTTATGATGTG 20 
68 AGACCAGAGGGAAACTATGCCC 22 
69 AGAGCTCTTGTTCTCTGATAGGTG 24 
73 AGCAAAAGCAGGAGTTTAAAATG 23 
74 AGCAAAAGCAGGAGTTTAAAATGAA 25 
75 AGCAAAAGCAGGAGTTTAAATGAAT 25 
76 AGCAAAAGCAGGCAAACCAT 20 
77 AGCAAAAGCAGGCAAACTATTTGAA 25 
79 AGCAAAAGCAGGGGAAAATAA 21 
80 AGCAAAAGCAGGGGAAAATAAAAAC 25 
82 AGCAAAAGCAGGGGATACAAAATG 24 
83 AGCAAAAGCAGGGGATACTTTC 22 
84 AGCAAAAGCAGGGGATATTTCTGTC 25 
85 AGCAAAAGCAGGGTAGATA 19 
134 
86 AGCAAAAGCAGGGTAGATAATCACT 25 
88 AGCAAAAGCAGGGTGACAA 19 
89 AGCAAAAGCAGGGTGACAAA 20 
90 AGCAAAAGCAGGGTGACAAAAACAT 25 
91 AGCAAAAGCAGGGTGACAAAGACA 24 
92 AGCAAAAGCAGGTACTGATCCAAAA 25 
93 AGCAAAAGCAGGTAGATATTG 21 
94 AGCAAAAGCAGGTAGATATTGAAAG 25 
95 AGCAAAAGCAGGTCAAATATATTCA 25 
96 AGCAAAGCTTTCAGCAACTG 20 
97 AGCAATGGCTCCAAACAGACC 21 
98 AGCAATGGCTTCAAACAGACC 21 
99 AGCACACATAACTGGAAACAATGC 24 
101 AGCAGGGGTATAATCTGTCA 20 
103 AGCATGAATTTTGCCAAGAG 20 
105 AGCCTGGCCTCAAGCTCATTGAA 23 
106 AGCCTTCTAACCGAGGTCGA 20 
108 AGCGTAGACGCTTTGTC 17 
109 AGCGTTCCTAGTTTTACTTGCAT 23 
110 AGCGTTCCTAGTTTTACTTGCATTGA 26 
112 AGGACAGAAGCCCTTATAGG 20 
113 AGGCGATCAAGAATCCACAA 20 
114 AGGGACAATTGGCACGGTTC 20 
115 AGGGACTGAAAAGGGTTGGACT 22 
117 AGGTTCATCACTATCATA 18 
118 AGTACCATCTTTTCTATTGT 20 
121 AGTAGAAACAAGGAGTTTTTT 21 
122 AGTAGAAACAAGGAGTTTTTTTCGT 25 
124 AGTAGAAACAAGGCATTTTTTCACG 25 
125 AGTAGAAACAAGGCATTTTTTCAT 24 
126 AGTAGAAACAAGGGTATT 18 
127 AGTAGAAACAAGGGTATTTTTC 22 
128 AGTAGAAACAAGGGTATTTTTCTTT 25 
131 AGTAGAAACAAGGGTGTTTTT 21 
132 AGTAGAAACAAGGGTGTTTTTAACT 25 
135 
133 AGTAGAAACAAGGGTGTTTTTAAT 24 
134 AGTAGAAACAAGGGTGTTTTTT 22 
135 AGTAGAAACAAGGGTGTTTTTTAT 24 
136 AGTAGAAACAAGGTACTTTTTTGGAC 26 
138 AGTAGAAACAAGGTAGTTTTT 21 
139 AGTAGAAACAAGGTAGTTTTTT 22 
140 AGTAGAAACAAGGTAGTTTTTTACT 25 
141 AGTAGAAACAAGGTAGTTTTTTACTC 26 
142 AGTAGAAACAAGGTCGTTTTTAAAC 25 
144 AGTTCCATGCTATTCCCCAG 20 
145 AGTTTTACTTGCATTGAATA 20 
146 ATAAACGCCCCTGGTAATCC 20 
147 ATAAAGATGCTAGTGGGTC 19 
148 ATAAGATCCTTCATTACTCAT 21 
149 ATAATGAGGTCAGATGCACC 20 
150 ATAATGTTTTTCTCATTACT 20 
151 ATACCAACCGTCTACCATTC 20 
152 ATACCATCCATCTACCATTCC 21 
153 ATAGGCTACCATGCGAACAA 20 
154 ATAGTCACGTTCAGCGCTG 19 
156 ATCAATCTGTCTGGTAGT 18 
157 ATCAATTTATTCCCACTTC 19 
158 ATCACTCACTGAGTGACATC 20 
159 ATCATTCCAGTCCATCCCCCTTCAAT 26 
160 ATCCCCGCGGTGCAACTAAG 20 
163 ATCTCTTTGTCCCATCCGTG 20 
166 ATGATGTGCCGGATTATGCC 20 
167 ATGCCTGAAACCGTACCAAC 20 
169 ATGGCCATCGGATCCTCAAC 20 
170 ATGGCTGCTTGAGTGCTT 18 
171 ATGGTAATGGTGTTTGGATAGGAAG 25 
172 ATGGTCCAGCTCAAGTTGTCA 21 
173 ATGTCGCTGTTTGGAGACAC 20 
174 ATGTTCCTTAGTCCTGTAACCAT 23 
176 ATTAAATAAGCTGAAACG 18 
136 
177 ATTACAGGATTTGCACCTTT 20 
178 ATTAGAGCGGAGAAAGGTGG 20 
179 ATTCCATCACCATTGTTCC 19 
180 ATTGAGAGGGTCAGTTGCTC 20 
181 ATTGGGACCTCTTCATAGAA 20 
184 ATTTCGCCAACAATTGCTCC 20 
186 ATTTCTTTGGCCCCATGGAATGT 23 
187 ATTTGTTATCCAGGCAAATT 20 
188 ATTTTCTATGAAACCTGCTATTGC 24 
192 CAAAGGCCCAGCCTTTCACT 20 
193 CAAATTCTCTATCCTCCTTTCCAA 24 
194 CAACATGCACCCTGGAGTGC 20 
195 CAACCATGAAGCCTCATCAGG 21 
196 CAACGGCCTCAAACTGAGTGT 21 
197 CAACTAAGTTGCCATTACTGT 21 
198 CAAGCGAATCTCTGTAGAGT 20 
199 CAATAGCTGGTTTTATAGAA 20 
200 CAATCATTTAGTTCTGCAGATG 22 
201 CAATGAAACCGGCAATGGCTCC 22 
202 CAATTGCATCGGGGGAG 17 
203 CACAACTTTCCCTTATACC 19 
204 CACAAGCACTGCCTGCTGTA 20 
205 CACAAGCACTGCCTGCTGTAC 21 
207 CACATTTGGCCTTTGGTTCC 20 
208 CACCCATATTGGGCAATTTCCTATGGC 27 
209 CACGCTCACCGTGCCCAGTG 20 
210 CACTGTCATACTTATTGTATTCGGA 25 
211 CAGAGACTTGAAGATGTCTT 20 
212 CAGAGACTTGAAGATGTCTTTGC 23 
213 CAGAGACTTGAAGATGTCTTTGCTG 25 
214 CAGAGGCCATGGATATTGCT 20 
215 CAGATGCAGACACAATATGT 20 
216 CAGATGCAGACACAATATGTATAGG 25 
217 CAGATTGAAGTGACTAATGC 20 
218 CAGCATTTTCTTGTGAGCTTCG 22 
137 
219 CAGCCATGCTTTTCCATCGTG 21 
220 CAGCTCTATGCTGACAAA 18 
221 CAGGGGATATTTCTGTCAATCATG 24 
222 CAGTAGCATTAGTCACTTCA 20 
223 CATAGATGTACCCATACAG 19 
225 CATCCTGTTGTATATGAGGCCCAT 24 
226 CATGGAATGGCTAAAGACAAGACC 24 
227 CATGGACTCAACTGTCATTC 20 
228 CATTCTGTTGTATATGAGGCCCAT 24 
229 CATTGCAAGCATGAGAAGGA 20 
231 CATTTTGCAAATCTCAAAGG 20 
232 CCAATCTACAGTATCACTATTCAC 24 
235 CCAGCAATAGCTCCGAAGAAA 21 
236 CCAGTGACAGAGAACCTGCTAC 22 
237 CCATAGACATCTTCGAAGC 19 
238 CCATGCATTCATTGTCACACTTGTGG 26 
240 CCATTGGGTCAATCTGTATGG 21 
241 CCCAGGGATCATTAATTAG 19 
242 CCCATTCTCATTACTGCTTC 20 
245 CCCTAATGTCTGGAGAAGCCAC 22 
246 CCCTCTTGTTGTTGCCGC 18 
248 CCGAGATCGCACAGAGACTTGAAGAT 26 
250 CCGAGATCGCGCAGAGACTTGAAGAT 26 
251 CCGATGATTGTCGAGCTTGC 20 
252 CCGTCAGGCCCCCTCAAAGC 20 
253 CCGTCAGGCCCCCTCAAAGCCGA 23 
254 CCGTCTACCATTCCCTCCCA 20 
256 CCGTGCTCGGGTGGTGAACC 20 
258 CCTATAATGCACGACAGAAC 20 
259 CCTCCAGTTTTCTTAGGATC 20 
260 CCTGAATTACAACCAGCAATGC 22 
261 CCTGACAGCAACTCCCTCAT 20 
262 CCTGAGCACACATAACTGGA 20 
265 CCTGCGATTGCGCCGAAT 18 
266 CCTGGGACATGCCCCATATG 20 
138 
267 CCTTCTGACCGAGGTCGAAAC 21 
268 CGAACTGTGTTATCATTCCATTCAAG 26 
269 CGAATCTGCACTGGGATAACATC 23 
270 CGAGTCTGCGGACATGAGTA 20 
273 CGATGCAATTGCAGGCACTT 20 
274 CGCAGCAAAAGCAGGGGATA 20 
275 CGCTTTGTGGTAGCCCTCCGT 21 
276 CGGACAACATGACCACAAC 19 
279 CGGGTTCGTTGCCTTTTCGTC 21 
280 CGGTAGCCATAACGAATCCGC 21 
281 CGGTATCAGAGTGGAACCCC 20 
282 CGTCAGCCATAGCAAATTTC 20 
283 CGTCTGAGCTCTTCAATGGT 20 
284 CTACAGAGACATAAGCATTTC 21 
285 CTATAAAGGCCCCATTAAAAC 21 
286 CTATCATTGCTTTGAGC 17 
287 CTATTGGGAGACCCTCATTGTGATGG 26 
288 CTCAGTTATTCTGCTGGTGCACTTGCCA 28 
289 CTCATGGAATGGCTAAAGACA 21 
292 CTCATTCTCCTGTTCACAGC 20 
293 CTCATTTCTTGATCTCCATG 20 
294 CTCCAAACAGACCTCTTTTT 20 
295 CTCCAGCTCTATGCTGACAAA 21 
296 CTCCATAGCCTTAGCCGTAGT 21 
297 CTCCCAGGAAACGACAACAG 20 
299 CTCGAGAGCAAAAGCAGGGT 20 
304 CTCTGAACCCACTGCTACAT 20 
305 CTCTGCATTGTCTCCGAAG 19 
306 CTCTGGCACTCCTTCCGTAG 20 
308 CTCTTCGGTGAAAGCCCTTAG 21 
309 CTCTTTAGATCTGCAGCTTGTCCTGTTCCTTC32 
310 CTGACATTGATTACAATTTG 20 
311 CTGATGTCGCAGTCTCGCAC 20 
312 CTGCAGCGTAGACGCTTTGTCCAAAATG 28 
313 CTGCTATTGCGCTGAATAG 19 
139 
314 CTGGGACATCATGCAGTGCCAAAC 24 
316 CTGTCAGTAAGTATGCTAGAGTCCC 25 
317 CTGTCGTGCATTATAGGAAAGCAC 24 
318 CTGTGGGAGCAAACCCG 17 
319 CTGTTAAGGGACAATGAAGC 20 
320 CTTAACAGTCCCATTTGA 18 
321 CTTAGAATGAAATGGATGAT 20 
322 CTTAGTCCTGTAACCATCCT 20 
323 CTTCGTCCCTTTGATGAAGC 20 
324 CTTCTAACCGAGGTCGAAACG 21 
325 CTTGATCGGCTTCGCCGAGATCAG 24 
326 CTTGTGAACTTCAAGTACCAAC 22 
327 CTTTCCCAACGGCTTCGAATTG 22 
328 GAAAAATTACACTGTTGGTTCGG 23 
329 GAAAAATTACACTGTTGGTTCGGTG 25 
331 GAAACAATGGGATTCAC 17 
334 GAAGATGAGCATCTCTTGGC 20 
335 GAAGCAGGGGTACTTTTCC 19 
336 GAAGCATCCATTCCCTATGTCTAC 24 
337 GAAGGCAAAGCAGAACTAGC 20 
338 GAAGGCAATAATTGTACTACTCAT 24 
339 GAAGTCTTCATTGATAAACTCCAG 24 
340 GAATCCAGCACACAAGAGTC 20 
341 GAATCTGCACTGGGATAACATC 22 
342 GAATGGATGTCAATCCGACC 20 
343 GACAAAGACATAATGGATCC 20 
345 GACATTTGAGAAAGCTTGCC 20 
346 GACCAGCACTGGAGCTAGGA 20 
347 GACCAGCACTGGAGCTAGGG 20 
348 GACCCCTTACCCAGGGTCTG 20 
349 GACCTTCTGATATTGTGGGGAA 22 
350 GACGATCAAGAATCCAC 17 
352 GACTATCATTGCTTTGAGC 19 
354 GAGCAAGGTAATAAAAGGGTCC 22 
355 GAGCAATTGCAACACCCG 18 
140 
356 GAGCAGCTGAAACTGCGGTG 20 
357 GAGCTGGTTCAGAGTTCCTC 20 
358 GAGGCACTTAAAATGACCAT 20 
361 GATAATCACTCACTGAGTGAC 21 
362 GATCAGAAGTCCCTAAGAGGAAGAG 25 
363 GATGCAGACACAATATGTATAGG 23 
364 GATTCGCCCTATTGACGAAA 20 
365 GATTGAAGTGACTAATGCTA 20 
366 GATTGATGTCCGCTCCATCAG 21 
367 GATTTGCCATAATGGATAC 19 
368 GCAAAAGCAGGGTGACAAAAAC 22 
369 GCAAAAGCAGGTAGATATTG 20 
370 GCAAAAGCTTCAATACTCCAC 21 
372 GCAAGAAACATTGTCTCTGGAGACC 25 
374 GCAATCAAAGGAGGTGGAACT 21 
375 GCACACTGATAGATGCTCTATTGGG 25 
377 GCAGATCCTGCACTGCAGAG 20 
378 GCAGGGGAAAATAAAAACAACC 22 
379 GCAGGGGAAAATAAAAGCCAC 21 
380 GCAGGGGAAACAATGCTATC 20 
381 GCAGTTTCCTATAGCAATCC 20 
383 GCATGCAATTCTGCTGCAT 19 
385 GCATTGTCTCCGAAGAAATAAG 22 
386 GCATTTCAATAGGGAAAAT 19 
387 GCATTTGGATCATCAAGC 18 
388 GCATTTTCTAATATCCACAA 20 
389 GCCACTCCACAATATACACCC 21 
390 GCCAGTAATACCAGCAATCTCG 22 
391 GCCAGTTTTTGGACGTCTTC 20 
394 GCGTATTTTGAAGTAACCCCG 21 
395 GCGTCGCGTTACCTAACCGA 20 
396 GCTACCTTCAACTATACAAACG 22 
397 GCTACTGAGCTGGTTCAGAGTTC 23 
398 GCTAGAATCAGGCCTTTCTT 20 
399 GCTCCAAGCAACATAGCACC 20 
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400 GCTCTGTCCATGTTATTTGGAT 22 
401 GCTCTGTCCATGTTATTTGGATC 23 
402 GCTGAAACGAGAAAGTTCTT 20 
403 GCTGCCCTGTCGGTGAAGCTCCGT 24 
404 GCTGCTTGTCCTGTGCCCTC 20 
405 GCTTCAAATGAGAACATGGA 20 
406 GCTTCCATCATCTGGTCTGG 20 
407 GCTTCCATTTGGAGTGATGC 20 
409 GCTTTTGCCCTCAACAGAGAAAAT 24 
412 GGACTGCAGCGTAGACGCTT 20 
413 GGATTGTTTGGGGCAATAGC 20 
414 GGCAAGTGCACCAGCAGAATAAC 23 
415 GGCAAGTGCACCAGCAGAATAACT 24 
417 GGCACCCTGGAGTTTATCAA 20 
419 GGCTGTCAGTAAGTATGCTA 20 
420 GGCTTCATACCCAACCATAGAG 22 
421 GGGAAAGATCCTAAGAAAAC 20 
422 GGGAATTGAACATATCGA 18 
424 GGGAGATTGCTGTTTATAGATCC 23 
426 GGGGCTTTCATAGCTCCAGATCGTGC 26 
433 GGTAGATATTGAAAGATG 18 
434 GGTGAAATCAAACATCTTCA 20 
435 GGTGACGAGAGAACCTTATG 20 
436 GGTGATGCCCCATTCCTTGA 20 
437 GGTGCATCTGACCTCATTATTGAG 24 
438 GGTGTGACGGCAGCATGCCCT 21 
439 GGTGTTCATCACCCGTCTAACAT 23 
440 GGTGTTTTTAACTACAATCTGG 22 
442 GTAAACACCCACATTCCAAACG 22 
443 GTAATCCCGTTAATGGCA 18 
444 GTACCTGCTTCTCAGTTC 18 
445 GTCAAGAGCACCGATTATCAC 21 
447 GTCAGCATCCACAGCACTCTGCTGTTCC 28 
448 GTCATACTCCTCTGCATTGT 20 
451 GTCCTTCCTATCCAAACACC 20 
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453 GTGACTGGTGTGATACCACT 20 
454 GTGACTGGTGTGATACCACTAAC 23 
455 GTGCAAACTGCATCTTGTGG 20 
457 GTGCCCAGTGAGCGAGGAC 19 
458 GTGCGTGTAAGAGAACAGTG 20 
459 GTGGAAACAGAGAAACAT 18 
460 GTGGCAATAACTAATCGGTCA 21 
461 GTGGGGTCATCAAAGTACAAC 21 
462 GTGGTAGCCCTCCGTCTTCTG 21 
463 GTGTTAGGAAGGAGTTGAAC 20 
464 GTGTTTGACACTTCGCGTCACAT 23 
465 GTTGAGGAGCTCTGGACTAG 20 
466 GTTGGGAGAAGAGCAACAGC 20 
467 GTTGTTTACATAGGACTTGCTCAG 24 
468 GTTTAGTCACTGGCAAACGG 20 
469 GTTTCTCTGGTACATTCCGC 20 
470 GTTTCTCTGGTACATTCCGCA 21 
472 TAAAGATATGCCTTCAAAAGCAA 23 
473 TAATCCTCTGCTGTGTCCCTCC 22 
474 TAATGCCTCATCAGGAGTGA 20 
476 TACACCCAGTCACAATAGGAGAGTG 25 
477 TACCAAATTGAGCGCTATGC 20 
478 TACCATACCTGTATGAAAACC 21 
481 TACGCTGCAGTCCTCGCTCA 20 
482 TACTTGTCAATGGTGAACGG 20 
483 TAGCAGAAGATTCACCCCAG 20 
486 TAGGAGACCCCCACTGTGAT 20 
487 TATAGGCTACCATGCGAACAA 21 
489 TATGCCTATAAAATTGTCAAG 21 
490 TATGGACCTGCCGTAGCC 18 
494 TCACAATGAGGGTCTCCCA 19 
495 TCACATATACTCCTTGCCA 19 
499 TCACTTTGCCGGTATCAGGG 20 
500 TCAGATTGAAGTGACTAATGCT 22 
502 TCATCGCCGAACAATTCACC 20 
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503 TCATTGGGATCTTGCAC 17 
504 TCCAGTTATGTGTGCTCAGG 20 
505 TCCCCTGCTCGTTGCTATGGTGG 23 
506 TCCCTTAGGTCACTAGTTGC 20 
507 TCCGAATAGGAACAATCACAGCTTGGTT 28 
508 TCCGGCACATCATAAGGG 18 
514 TCCTCTGCATTGTCTCCG 18 
515 TCCTGTCACCTCTGACTAAGGGGATTTTG 29 
518 TCGGTAGCCATAACGAATCC 20 
519 TCGTCAGCATCCACAGCA 18 
520 TCTAATTGCCCCTTGGTATG 20 
521 TCTAGTTTGTTTCTCTGGTA 20 
522 TCTAGTTTGTTTTTCTGGTACAT 23 
524 TCTCATTTTGCAAATCTCAAAGG 23 
525 TCTCCTTGTGCATTTTGATGC 21 
526 TCTCCTTGTGCATTTTGATGCC 22 
528 TCTCTTGCTCCACTTCAAGC 20 
529 TCTGCAATGTAGGACCATGA 20 
530 TCTGCTTCACCAATTAAAGG 20 
531 TCTGTCCATCCATTAGGATCC 21 
533 TCTTCAATGGTGGAACAG 18 
534 TCTTCGGTGAAGGCCCTTAGTAAT 24 
535 TCTTTCTGGCACGGTCTG 18 
536 TGAAAGATGAGCCTTCTAACCGA 23 
538 TGAAGTGACTAATGCTACTG 20 
540 TGAATGAGTTGGGTGTTCCATTTCA 25 
541 TGACTGGGTGTACATTCTGG 20 
542 TGAGGACCCAAGTCACGA 18 
543 TGAGGGAGCAATTGAGCTCA 20 
544 TGAGTTGGGTGTTCCATTTC 20 
546 TGATCATCCTGACCAATTCCAT 22 
547 TGATGTATGCCCCACATGAA 20 
548 TGATTTGGGATCCTAATGGATGGACAG 27 
549 TGCACCATGTAATCAACAACAA 22 
551 TGCACTTTCCATCATCCTTA 20 
144 
552 TGCATGTTCTCCTGTGTAGTAAG 23 
553 TGCCTCAAATATTATTGTGT 20 
554 TGCCTCAAATATTATTGTGTC 21 
555 TGCCTCAAATATTATTGTGTCCCCGGGT 28 
556 TGCGATGCTCAGGACGTT 18 
557 TGCGGGGAAGGATCCTAAGAAAAC 24 
558 TGCTCCCTCTTCGGTGA 17 
559 TGCTCTAAGCAAGCAAGCTG 20 
560 TGCTGAGCACTTCCTGACAATGGGCT 26 
561 TGCTGGGAGTCAGCAATCTG 20 
562 TGGAAGATTTTGTGCGAC 18 
563 TGGAGGCAATCTGCTTCACC 20 
564 TGGATGGCATGCCACTCTGC 20 
565 TGGCCTTCTGCTATTTCAAA 20 
566 TGGCGCCAAGCGAACAATGGAGAAGA 26 
567 TGGGCTGTCTCTGGTTATTC 20 
568 TGGTACATTCCGCATCCCTG 20 
569 TGTCAGCTATTATGGAGCTG 20 
570 TGTCGCTGTTTGGAGACACA 20 
573 TGTTCCTGTTACCCTCGATATCC 23 
574 TGTTGCACCTAATGTTGCC 19 
575 TGTTTTCACCCATATTGGGC 20 
578 TTACACTGTTGGTTCGGTGG 20 
579 TTACGAACAGATGGAGACT 19 
580 TTACTCCAGCTCTATGCTGA 20 
581 TTACTGTTAGACGGGTGAT 19 
582 TTAGCTCAGGATGTTGAACG 20 
583 TTATCATACAGATTCTTGAC 20 
584 TTCCAACTCCTTTGACTGCAGCAC 24 
585 TTCCATTGATCTGGTCGATGGCTG 24 
587 TTCGCCCAAAAACTTCCCGG 20 
588 TTCTACTAGACAGACCCCTTACCC 24 
589 TTCTAGCTGAGAGAAAAATGAGAAGATGT 29 
591 TTGAAATATCCCCGCGGTGC 20 
592 TTGAACGCAGCAAAGCTTTCAGCA 24 
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593 TTGAATGGATGTCAATCCGA 20 
596 TTGCCATCCTGGCAACTACTGT 22 
597 TTGCTGGTTTTATTGAGGGG 20 
598 TTGCTTGGTCAGCAAGTGCA 20 
599 TTGGAACCTCAGGATCTTGCC 21 
600 TTGGGATATTGCCCGACA 18 
601 TTGGGGGGTTCACCACC 17 
602 TTGGGTCAGTGAGGGAAAAC 20 
603 TTGTCTCCGAAGAAATAAGA 20 
604 TTGTTGAACGCAGCAAAGCT 20 
606 TTTCACCACTGCCCTCTCTT 20 
607 TTTCTAATATCCACAAAATGA 21 
608 TTTCTAATATCCACAAAATGAAGGC 25 
609 TTTGGGAAGCCACCAATCTG 20 
Kl CTACAGTCAAAACCCAACC 19 
KlO CCCCACTGTGATGTCTTCC 19 
K3 TACAGTCAAAACCCAACC 18 
K4 TGCTACCCATATGACATCC 19 
K5 ATTGCTACCCATATGACATCC 21 
K51 TGTTAGCCAATTCAGTCG 18 
K52 ATTGACCCCTAACCCACG 18 
K54 TATCCTGCCTGATTGACC 18 
K55 CTTATCCTGCCTGATTGACC 20 
K56 TTATCCTGCCTGATTGACC 19 
K58 TGCTTATCCTGCCTGATTGACC 22 
K59 CTGCCTGATTGACCCCTAACC 21 
K8 ACCCCCACTGTGATGTCTTCC 21 
K2 GGACCTCTTCATAGAAAGAAGC 22 
Uni3 AGCAAAAGCAGG 12 
Uni5 AGTAGAAACAAG 12 
"Total 480, Average" 21.1 
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Appendix 2: Homemade Scripts and Descriptions 
LMS related mes 
LMS provides a list of literature whose entries need to be prepared for the 
VirOligo entries (See diagram A). 
Configuration file name: PMID.config (text) 
Description "This text file is LMS configuration file. Lists new and updated virus 
names." 
Script name: l_lst_ VisitTo_NCBI (perl) 
Description "This script accesses PubMed, downloads all PMIDs for queries in 
PMID.config file, and stores only unique PMIDs to MySQL database." 
Script name: 2_Insert_FM_DataID (perl) 
Description "This script accesses the VirOligo entry server and updates completed 
PMIDs in MySQL database." 
Script name: 3_2nd_ VisitTo_NCBI (perl) 
Description "This script accesses PubMed, and retrieves author's name, journal 
title, volume number, page number, date published, and article title for each article, 
which has not been entered to the database. Then, the script stores the retrieved 
information in MySQL database." 
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Table name: PMID (MySQL) 
Description "This table stores literature information from PubMed." 
Table name: Copied (MySQL) 
Description "This table stores a list of waiting articles, for which Inter-Library 
loan is requested or searching and copying is in process." 
Table name: Ref (MySQL) 
Description "This table stores journal locations, Call numbers or web addresses." 
Script name: PMID _request.php (PHP) 
Description "This is a user interface for LMS. The script searches a MySQL 
table, PMID, according to the user selection and finds a location of the journal from a 
MySQL table, Ref. At the same time, the script excludes the articles other users 
requested within a certain time according to a MySQL table, Copied." 
Script name: unlisted.php (PHP) 
Description "This script compares two MySQL tables, PMID and Ref, and lists 
journal names not listed in Ref. Journals not listed in Ref need call numbers or web 
addresses entered in Ref manually." 
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Script name: unlistedvolume.php (PHP) 
Description "This script compares two MySQL tables, PMID and Ref, and lists 
volumes of journal not listed in Ref. Library is not subscribing to all volumes of a 
journal. Thus, additional information for particular volumes or issues is required in Ref." 
VirOligo database related files for the publishing server program (Diagram B) 
Table name: datl (MySQL) 
Description "This table stores common data. datl and dat2 are the relational 
database" 
Table name: dat2 (MySQL) 
Description "This table stores primer data. datl and dat2 are the relational 
database" 
Script name: main.php (PHP) 
Description "This is a user interface for a VirOligo database search. The script 
searches datl for Data ID, virus names, or PMID, or searches dat2 for oligo length, Tm, 
or sequence according to user's interest, and returns a summary of a search result. If a 
user selects a VirOligo ID, the script returns detailed information about the entry with the 
VirOligo ID. The script also look for GI, PMID, Data ID, and entries with the same 
oligonucleotide sequence and adds links to the result." 
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Script name: chformat.pl (Perl) 
Description "This script is used for changing a data format of datl and dat2. FMP 
database format is not acceptable for MySQL database. The script change FMP database 
HTM export format to MySQL "load" command acceptable format." 
Script name: primer.php (PHP) 
Description "This is a user interface for data entry. The script is only used for 
volunteer entries from anonymous people. The script receives a Common data entry and 
a Primer data entry, and returns a primer-entry-page or transfers to "thankyou.php". The 
entries are stored to MySQL database but these entries are not searchable by "main.php" 
until curator's approval." 
Script name: thankyou.php (PHP) 
Description "This script is used after finishing a volunteer entry and emails a 
notice to the curator of VirOligo database." 
Data Analysis related scripts 
Script name: tmcal.php (PHP) 
Description "This script calculates a Tm by nearest-neighbor method. Only one 
sequence can be processed at a time. The sequence can contain numbers and spaces, and 
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the script ignores these characters. Thus, the sequence can be directly pasted from NCBI 
Entrez page, which contains nucleotide position in each line and a space every 10 hp." 
Script name: 2tmcal.php (PHP) 
Description "This script calculates Tms by nearest-neighbor method. Multiple 
sequences can be processed at a time. Sequences can be separated by spaces, tabs, and 
carriage returns. A Java script in "2tmcal.php" calculates salt concentration from 
magnesium and potassium concentrations." 
Script name: I-counter.pl (Perl) 
Description "This script counts the number of unique sequences or IDs. Before 
counting, a file must be sorted by Excel program and exported by Tab-delimited text 
format." 
Script name: 4-counterMakeResfile.pl (Perl) 
Description "This script counts and creates a file with unique sequences or IDs. 
Before processing, a target file must be sorted by Excel program and exported by Tab-
delimited text format." 
Script name: 2-TmofProductbyGenBankR.esult (Perl) 
Description "This script calculates %GC and Tm of PCR products from GI and 
target locations by accessing NCBI. The script consists of two processes.' First, the script 
provides primer pair selection interface. Some entries contain more than one pair of 
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primers and primer pairs need to be selected according to notes in the VirOligo database. 
If only two primers are registered in an entry, the script reads target locations of primers 
and determines a target location of PCR product. If there are more than 2 primers in an 
entry, the script shows primers and notes from the entry and asks a user to select primer 
pairs. After all entries are processed, the script generates a file with target locations of 
PCR products and GI numbers. 
Then, the script accesses Genbank and obtains sequence data according to the GI 
numbers in the file generated above. The script obtains PCR product sequences from the 
sequence data and target location, and calculates %GC and Tm." 
Script name: 8-splice (Perl) 
Description "This script generates sequence fragments in a user-selected size from 
a PASTA format file. If a user selects 20-bp fragments for a 135,301-bp BHV-1 
sequence, the script creates a 20-bp fragment from 5' end ofBHV-1 sequence and makes 
more 20-bp fragments by shifting 1 bp to 3' end until a 20-bp fragment reaches 3' end of 
BHV-1 sequence. At the end, the script generates a file with 135,282 20-bp fragments." 
ViSH chip Oligonucleotide Selection Related Files 
Table name: blast2 (MySQL) 
Description "This table stores BLAST results for oligonucleotides generated by 
primer design program." 
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Table name: blast3 (MySQL) 
Description "This script stores BLAST results for influenza-specific 
oligonucleotides from VirOligo database." 
Script name: blast2.php (PHP) 
Description "This is a user interface for a MySQL table, blast2. The script shows 
all sequences in the blast2 table. If user selects a sequence, the script shows a BLAST 
result for the sequence from the blast2 table. The script also defines conserved sequences 
or non-conserved sequences according to the number of perfect-matches in BLAST 
results." 
Script name: blast3.php (PHP) 
Description "This is a user interface for a MySQL table, blast3. The script shows 
all sequences in the blast3 table. If user selects a sequence, the script shows a BLAST 
result for the sequence from the blast3 table. The script also can create a table with all 
sequences, length of sequences, matched stands, matched lengths, and first five matched 
organism names for each sequence." 
Script name: mainProgForBLAST.pl (Perl) 
Description "This script accesses NCBI BLAST and stores the BLAST results in 
MySQL database. The script consists of three steps for faster process. First, the script 
reads a sequence file, sends each sequence to BLAST, and obtains a RID for each 
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sequence. The RID is the BLAST processing ID number from NCBI and is assigned to 
each BLAST request. Second, the script sends a last RID to NCBI every 60 seconds and 
checks whether the last BLAST request is completed. Third, the script sends RIDs, 
obtains BLAST results, and stores to MySQL database." 
Script name: blast.php.pl (Perl) 
Description "This script searches a MySQL table, blast3, and finds 
oligonucleotide length, matched length in BLAST, and strand matched. The script also 
selects organisms from BLAST results within a user-selected range of mismatches, and 
reports organism names other than influenza virus. The script generates HTML table 
format files for easier pasting to Excel spread sheet." 
Vir0Iigo database related files for the entry server 
Diagram C shows the data entry process. In addition to the diagram, there are 
curator's options to check and fix entries; manage personnel; help molarity calculations. 
Due to security concerns, script names and functions of scripts are not listed here. All 
scripts are written by Java script, FMP script, or FMP web language (CDML). 
Molarity calculation script (Java script) 
Description "This script calculates final concentration from initial concentration, 
initial volume, and total volume. The script can handle additions ofreagents at RT 
and/or PCR." 
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Table name: time.fp3 (FMP) 
Description "This table is used as a punch-clock for entry persons" 
Excel spread sheet: Timesheet.xlm 
Description "This excel spread sheet functions calculates the number of hours 
worked in any given time or total hours worked for each person or a group. Data is 
pasted from a FMP table, time.fp3." 
Script name: perform script all 
Description: "This script calculates Tm for each oligonucleotide based on %GC 
method." 
Script name: delete un-linked date 
Description: "FMP creates an empty entry only with Data ID sometimes due to 
bugs in the FMP. The script removes such empty entries." 
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Appendix 3: IRB Form 
Date: Friday, July 26, 2002 
Oklahoma State University 
Institutional Review Board 
Protocol Expires: 7/25/2003 
IRB Application No AG033 
Proposal Title: COMPARISON OF INDIVIDUAL ANO GROUP WORK IN VirOligo DATABASE ENTRY 
Principal 
lnvestigator(s): 
Kenji Onodera 
246 Noble Research Center 
Stillwater, OK 74078 
Reviewed and 
Processed as: Exempt 
Ulrich Melcher 
246 Noble Research Center 
Stlllwater, OK 74078 
Approval Status Recommended by Reviewer(s): Approved 
Dear Pl: 
Your IRB application referenced above has been approved for one calendar year. Please make note of the 
expiration date indicated above. It is the judgment of the reviewers that the rights and welfare of individuals 
who may be asked to participate in this study will be respected, and that the research will be conducted in a 
manner consisten t with the IRB requirements as outlined in section 45 CFR 46. 
As Principal Investigator, it is your responsibility to do the following: 
1. Conduct this study exactly as it has been approved. Any modifications to the research protocol 
must be submitted with the appropriate signatures for IRB approval. 
2. Submit a request for continuation if the study extends beyond the approval period of one calendar year. 
This continuation must receive IRB review and approval before the research can continue. 
3. Report any adverse events to the IRB Chair promptly, Adverse events are those which are 
unanticipated and impact the subjects during the course of this research; and 
4. Notify the IRB office in writing when your research project is complete. 
Please note that approved projects are subject to monitoring by the IRB. If you have questions about the IRB 
procedures or need any assistance from the Board. please contact Sharon Bacher, the Executive Secretary to 
the IRB, in 415 Whitehurst (phone: 405-744-5700. sbacher@okstate.edu). 
~
·ncerel.y, 
lJ 
·1 t 
Carol Olson, Chair 
Institutional Review Board 
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